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Abstract 
Despite the intensive research of the past decades in oncology, cancer invasion and 
metastasis still represent the most important problem for treatment and the most 
common cause of death in cancer patients. Metastasis refers to the spread of malignant 
cells from a primary tumour to distant sites of the body and the adaptation of these 
cancer cells to a new and different tissue microenvironment. Usually, millions of cells 
can be released by a tumour into the circulation every day, but only a tiny minority of 
these cells are able to reach and colonize a distant organs: the utter inefficiency of the 
metastatic process implies that cells might strongly need biomechanical alterations that 
allow them to invade and colonize different tissues. The hypothesis that cellular 
biomechanics may play a significant role in tumour genesis and cancer invasion, gains 
every day more and more support: therefore characterizing these properties in 
connection with the membrane and cytoskeleton organization could be very important 
for understanding better the migration mechanisms and to develop new diagnostics and 
therapeutics tools. 
The goal of our study was the mechanical characterization of cell lines chosen as model 
of cancer progression using different biophysical techniques and the correlation of the 
mechanical properties with possible alterations of the cytoskeleton structure and plasma 
membrane composition. 
We used a custom built Optical Tweezers to extract the local viscoelastic properties of 
the cell plasma membrane, an Atomic Force Microscopy (AFM) to locally measure cell 
elasticity of cells, and a Microfluidic Optical Stretcher to measure the deformability of 
cells as whole bodies. We investigated then the actin organization of the cytoskeleton 
by STimulated Depletion and Emission (STED) and confocal microscopy. The lipid 
composition of cells was analysed by MALDI-mass spectroscopy in order to correlate 
the mechanical alterations of cells with alteration at the cytoskeleton and plasma 
membrane level. The techniques for cell biomechanical experiments are described in 
3.1, while the imaging and spectroscopy techniques and described in detail in 3.3 and 
3.4. 
The cell lines analyzed derive from breast tissue and represent a model of human 
epithelial cells towards malignancy. In particular, two cell lines -MDA-MB-231 and 
MCF-7- provided by American Type Culture Collection (ATCC) were originally 
derived from breast cancers patients with different level of  cancer aggressiveness. 
Cells were chosen according to the nowadays accepted classification of breast cancer 
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based on gene expression pattern and proteomic expression, which divide breast 
cancers in subtypes that differ in terms of risk factor, distribution, prognosis, 
therapeutic treatment responsiveness, clinical outcomes and survival. The third cell 
line, HBL-100, is an immortalized but non-neoplastic cell line derived from the milk of 
a nursing mother with no evidence of breast lesions, representing a earlier stage of the 
cell transformation. Cell lines description is reported in detail in 2.1. 
A pulling membrane tether approach by means of Optical Tweezers has been chosen 
since it allows an accurate quantitative characterization of local viscoelastic properties 
of plasma membranes. Bovine Serum Albumine (BSA) coated silica beads were used to 
bind the plasma membrane and grab membrane tethers of several microns measuring 
the force exerted on the bead. By fitting with the Kelvin body model our force-
elongation curves obtained by experimental data we extracted the parameters of 
interest: tether stiffness, membrane bending rigidity, and tether viscosity. The Optical 
Tweezers setup and experimental approach are described in 2.2.1.We observed that 
lower values of tether stiffness and membrane bending rigidity corresponded to cells 
associated to a higher aggressive behaviour, while viscosity showed an inverse 
tendency.  
We also probed elasticity of the cells using by indentation experiments with AFM. We 
used a bead probe attached to the cantilever and measured the Young Modulus. The 
technique is described in 2.2.2. The results obtained could not clearly discriminate the 
three cell types in terms of elasticity. 
Cell deformability was further investigated by means of Microfluidic Optical Stretcher. 
Cells in suspension were trapped by two counter propagating laser beams of low 
intensity from two optical fibers. Adjusting the intensity of the laser light, the forces 
acting on the cell surface increased, leading to a measurable elongation of the cell body 
along the laser beam axis. With MOS we were able to discriminate between cancer and 
control cells lines, while differences between the two cancer cell lines were not 
significant. However a trend could be observed: lower aggressive tumour cells were 
more resistant to deformation compared to the higher aggressive tumour cells. This 
technique is described in 2.2.3. 
The results of the mechanical analysis are reported in 3.1 
We investigated the cells cytoskeleton structure by STED and confocal microscopy 
confirming that malignancy involves cytoskeleton structure alterations. Differences in 
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the organization. of the actin filaments and in the presence of actin drifts were 
observed. We peformed also a preliminary analysis of the cell lipid composition by 
MALDI MASS spectroscopy. We could observe that highly aggressive cells with softer 
membranes presented alterations at the level of Phosphatidylethanolamines (PEs)  and 
Phosphatidylinositoles (PIs). STED and confocal images, and MALDI mass spectra are 
reported in 3.3 and 3.4. 
The work of this thesis is partially published in the article “Custom Built Optical 
Tweezers for locally probing the viscoelastic properties of cancer cells” in the 
International Journal of Optomechatronics (June 2011). A second article including the 
comparative results of the biomechanical analysis on the breast cell lines is in 
preparation. 
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1. INTRODUCTION 
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1.1 Cancer and metastasis  
Despite the intensive research in oncology, cancer invasion and metastasis are still 
unsolved problems, representing the most common cause of death in cancer patients 
and the main problem for cancer treatment. The spreading of tumors cells from primary 
site to other tissues is the results of different events. Physiology, therapy, tumor type 
are some of the variables which compete with this complex phenomenon and represent 
the reason why patients with the same tumor type and stage present completely 
different outcome.  
Cancers of the lung and bronchus, colon and rectum, prostate and breast respectively 
for males and females continue to be the most common fatal cancers and account for 
half of the total deaths in industrialized countries. In the last decades, due to the great 
advances that have been made in the understanding of the molecular, genetic and 
environmental factor that influence the onset and the progression of cancer, mortality 
rates have continued to decrease across all these four major cancer sites in both men 
and women–except for female lung cancer in which death rates are continuing to 
increase. However, the incidence trends are mixed (Jemal A., Siegel R. et al. 2008) and 
some cancer type’s incidence rates are increasing due to bad life style, diet and 
exposure to risk factors, but also for longer life duration and screening programs that 
lead to more frequent diagnosis. 
In figure 1.1 the annual age-adjusted cancer incidence and mortality rates (by sex/ by 
sex for selected cancers) in United States from 1975 to 2004 are reported. 
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Figura 1.1: Cancer incidence and death rates. 
Figure report the annual age-adjusted cancer incidence and death rates for all sites by sex in United 
States from 1975 to 2004. Rates are age-adjusted to the 2000 US standard population. Incidence rates are 
adjusted for delays in reporting. Adapted from Jermal A et al.2008.  
The most common cause of death in cancer patients with solid tumors is metastasis, 
accounting for 90% of the deaths but still the mechanism is not completely understood. 
In physiological conditions tissues are only seemingly static, cell division is controlled 
by continuous stimulatory and inhibitory signals that maintain tissues homeostasis. 
When a normal cell switches its phenotype and becomes a neoplastic cell, genetic and 
epigenetic mutations occur altering this equilibrium: diseased cells proliferate 
uncontrollably and disrupt the organization of tissue causing cancer formation. 
Malignant transformation is the process in which a cell changes morphology over time 
from a benign phenotype into an invasive or metastatic entity undergoing many genetic 
and epigenetic changes: these oncogenic events, such evasion of growth suppression or 
DNA-damage checkpoints create the genomic instability that contributes to the 
evolution of tumours to the metastatic state (Gupta G.P. and Massaguè . 2006). 
This transformation leads to a progressive loss of tissue homeostasis and stereotypic 
alterations in the tissue architecture that ultimately culminates in tumor cell invasion of 
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the parenchyma and metastasis to distant organ sites. (Kumar and Weaver 2009): it 
occurs in a series of steps which have been described as a  “metastatic cascade” (Geiger 
T.R. and D.S 2009). The detailed description of the metastatic process in a solid tumor 
is reported in fig.1.2. 
As mentioned above, after neoplastic transformation cells proliferate uncontrollably as 
benign tumour forming a mass in the epithelial tissue until genetic alterations allow 
them to break through the basal membrane and reach the extra cellular matrix (ECM), 
invading capillaries. Once tumour cells enter the bloody or lymphatic system they can 
travel through the vessels to another site, even distant from the primary tumour. 
Circulating Tumoral cells (CTCs) must adhere the vessel walls before they can 
extravasate: if the microenvironment is established, the tumor cell(s) may proliferate at 
this distant site and eventually form lethal metastases. 
 
 
Figure 1.2: Metastatic cascade.  
(a) Cells grow as benign tumor (b) Cells break through the basement membrane (c) Invasion and Travel 
through the blood stream (d) Adhere to capillary wall (e) Escape from blood vessel (Extravasation) (f) 
cells proliferate to form metastases adapted from Alberts B. et al,  Molecular Biology of the Cell 4th ed. 
New York Garland 2002, p1325 
Metastasis is an inefficient process: only few cells survive after the travel through the 
circulation system and are potentially able to form metastasis: it requires many 
mechanisms as matrix degradation, cell migration, evasion of host immune response, 
metastatic colonization and angiogenesis for the survival of cells forming the secondary 
tumour. It is accompanied by phenomena like the epithelial-mesenchymal transition 
(EMT) which means the loss of cell polarity, the alterations of the cytoskeleton 
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structure and membrane modifications that reflect in changes at the level of 
proliferation rates, cell survival, cell mechanical properties and in the ability to attach 
move and spread in host healthy tissues. 
1.2 Breast cancer 
1.2.1 Breast cancer: epidemiology and risk factors 
Invasive breast cancer is the most frequent carcinoma in females: it accounts for 22% 
of all female cancers (Parkin D.M., Bray F. et al. 2001) The areas of higher risk are the 
affluent populations of North America, Europe, Australia and countries that have 
acquired the Western lifestyle. In regions which have featured this lifestyle for a long 
period of time (North America, Northern Europe, Australia) the disease had been 
increasing until the early 1980s and then reached a plateau of an incidence rate of 70 to 
90 new cases per 100,000 population/year while countries that have more recently 
become industrialized and affluent show a marked increase in incidence and mortality 
(Tavassoli F. A. and Devilee Peter. 2000).  
Despite the increasing incidence of breast cancer in some areas encouraging trends 
have been observed regarding mortality and survival over the past decades. Since the 
late 1970s significant improvements in survival have been recorded in western 
countries since the late 1970s (Adami H.O., Sparen P. et al. 1989; Chu K.C., Tarone 
R.E. et al. 1996) and the mortality trend declined in several high risk countries (WHO 
2000):  this reflects a combination of factors such as earlier diagnosis due to population 
screening programmes, more efficacious adjuvant hormonal treatments and systemic 
therapy.  
Geographical variations and studies of populations migrating from low to high risk 
areas show that migrant populations approach the risk of the host country in one or two 
generations (Balzi D., Buiatti E. et al. 1993; Ziegler R.G., Hoover R.N. et al. 1993; 
Kliewer E.V. and Smith K.R. 1995) suggesting that breast cancer is a multifactorial 
disease and its aetiology involves mainly environmental factors. These risk factors are:  
diet and physical activity, reproductive factors, related hormonal imbalances and 
exposure to ionizing radiation. An overview of the main risks factors is reported in this 
section and summarized in Fig. 1.3. 
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Figure 1.3: Aeziological factor involved in breast cancer incidence  
Adapted from Tavassoli F.A. et al. 2000.   
1.2.2 Breast cancer classification  
Invasive breast carcinoma is  a group of malignant epithelial tumours characterized by 
invasion of adjacent tissues and a marked tendency to metastasize to distant sites.  
Breast cancer’s heterogeneity arises from many different factors,  such as the cell of 
origin, the molecular alterations causing them and the susceptibility and defences of the 
patient. All this makes difficult to give the most appropriate treatment and 
prognosticate the clinical outcome (Bertucci F. and Birnbaum D. 2008) 
Thus, several parameters, such as histopathological type, histopatological grade, stage, 
receptor status and the present or absence of particular genes, are used to classify breast 
cancer and each of them influences treatment response and prognosis. The next sections 
provide a brief description of  these parameters 
Histopathological classification 
The basic component of the breast is the mammary gland. Each mammary gland, 
whose structure is reported in figure 1.4 , is made of multiple lobules connected to 
ducts and surrounding tissue, which includes blood vessels. Breast malignant lesions 
may arise from any of these structures giving rise to different types of tumours 
exhibiting a wide range of morphological phenotypes and specific histopathological 
types with particular prognostic or clinical characteristics (Tavassoli F. A. and Devilee 
Peter. 2000). 
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Figure 1.4:Mammary gland normal anatomy and associated pathologies. 
The whole mammary gland (left) and the terminal duct lobular unit (right) are represented and  
associated to their correlated pathologies. (copyright 2004,2000, 1995 by Elsevier Inc.) 
The vast majority of breast tumours are adenocarcinomas whose origin is referred to 
the mammary parenchymal epithelium, particularly cells of the terminal duct lobular 
unit. 
Despite the wide and complex histological classification of breast cancers, here the 
most common types are reported: ductal carcinoma in situ (DCIS) and lobular 
carcinoma in situ (LCIS), invasive ductal carcinoma (IDC),  and invasive lobular 
carcinoma (ILC)  
Ductal carcinoma in situ (DCIS) 
It consist of malignant epithelial cells confined to the mammary ducts without 
microscopic evidence of invasion through the basement membrane into the surrounding 
tissue: according to the tumour differentiation DCIS can be further divided into low, 
intermediate and high grade with prognostic implications. 
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Lobular carcinoma in situ (LCIS) 
By definition, these cancer cells are characterized by a solid proliferation of small cells 
confined to the mammary lobules without invasion. This type of tumour generally lacks 
specific clinical or mammographic signs and occurs more frequently in premenopausal 
women.  
Invasive ductal carcinoma (IDC) 
Invasive ductal carcinoma comprises the largest group of invasive breast cancers. It is a 
heterogeneous group of tumours that fail to exhibit sufficient characteristics to achieve 
classification as a specific histological type, such as lobular or tubular carcinoma. It is 
the most common 'type' of invasive carcinoma of the breast comprising between 40% 
and 75% in published series (Tavassoli F. A. 2003; Rakha E.A., Putti T.C. et al. 2006) 
The morphological macroscopical features vary considerably from case to case: there is 
a marked variation in size (10-100 mm) with an irregular, stellate outline or nodular 
configuration. Invasive ductal carcinoma commonly spreads to the regional lymph 
nodes and carries the poorest prognosis among various ductal types.  
Invasive lobular carcinoma (ILC) 
Invasive lobular carcinoma (ILC) is composed of non-cohesive cells individually 
dispersed or arranged in single-file linear pattern in a fibrous stroma. These infiltrating 
cords frequently present a concentric pattern around normal ducts and the mean 
diameter has been reported to be slightly larger than that of IDC in some 
series(Silverstein M.J., Lewinsky B.S. et al. 1994; Sastre-Garau X., Jouve M. et al. 
1996; Winchester D.J., Chang H.R. et al. 1998). Invasive lobular carcinoma represents 
5-15% of invasive breast tumours (Martinez V., Azzopardi J.G. et al. 1979; du Toit 
R.S., Locker A.P. et al. 1989; Ellis I.O., Galea M. et al. 1992; Sastre-Garau X., Jouve 
M. et al. 1996; Toikkanen S., Pylkkanen L. et al. 1997; Winchester D.J., Chang H.R. et 
al. 1998). ILC can be difficult to define macroscopically because of the the irregular 
and poor delimited tumours and the diffuse growth pattern of the cell infiltrate 
(Silverstein M.J., Lewinsky B.S. et al. 1994). 
Ductal and lobular carcinomas incidence rates are followed by more rare malignancies 
arising from other connective tissues such as Tubular carcinoma, Medullary carcinoma 
and Paget’s disease of the nipple. The description of all histological breast cancer 
subtypes is beyond the scope of this manuscript, for a detailed analysis see (Tavassoli 
F. A. 2003). 
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Tumour size and lymphonode involvement status: the TNM classification 
The tumour size, the lymphonode involvement and whether the tumor has metastatized 
or not contribute to predict the patient clinical outcome and can be useful for the 
therapeutic choice. In particular the status of the axillary lymph nodes is actually one of 
the most important prognostic factor for patients with breast cancer. Numerous studies 
have shown that disease - free and overall survival rates decrease as the number of 
positive nodes increases (Fisher B., Dignam J. et al. 1999). Together  with the 
lymphonode status, also tumour size is an important prognostic factor, however the 
methods  reporting the pathological tumour size varies.  Pathologists report varies 
according to : the macroscopic size of tumor , the microscopic size which includes both 
the invasive and in situ components and the microscopic size of the invasive 
component only. There is often poor correlation between the tumour size determined by 
gross pathological examination and the size of the invasive component as determined 
by histological measurements (Abner A.L., Collins L. et al. 1998). The size of the 
invasive component is clinically significant, and so the pathological tumour size for 
classification is a measurement of the only invasive component (Verlag 2002). 
Therefore the microscopic size prevales, when there is a discrepancy between the gross 
and the microscopic size of the invasive component.  
Taken together the size of the primary tumour, the presence of metastatic regional 
lymph nodes and/or of distant metastases are the key elements for the so called TNM 
categorization (Veronesi U., Viale G. et al. 2005). This staging system classifies 
cancers based on their T, N, and M stages. Briefly, the letter T followed by a number 
from 0 to 4 describes the tumor's size and spread to the skin or to the chest wall under 
the breast. Higher T numbers mean a larger tumor and/or wider spread to tissues near 
the breast. The letter N followed by a number from 0 to 3 indicates whether the cancer 
has spread to lymph nodes near the breast and, if so, how many lymph nodes are 
affected. Finally, the final M followed by a 0 or 1 indicates whether the cancer has 
spread to distant organs (1) or not (0).  
Histological Grade 
The histological grade focuses on the appearance of the breast cancer cells compared to 
the appearance of normal breast tissue. During cell progression towards malignancy, 
cells that would normally line up in an orderly way to make up the milk ducts become 
disorganized, lose their differentiation and start to proliferate uncontrollably. Cell 
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nuclei become less uniform. Pathologists divide cells into 3 categories: highly 
differentiated (low grade), moderately differentiated (intermediate grade), and poorly 
differentiated (high grade) as the cells progressively lose the features seen in normal 
breast cells.  
Grading is recommended for all invasive carcinomas of the breast, regardless of 
morphological type (Pereira H., Pinder S.E. et al. 1995; Commission 1996). Higher 
rates of distant metastasis and poorer survival are observed in patients with higher 
grade (poorly differentiated) tumours, independent of lymph node status and tumour 
size (Contesso G., Mouriesse H et al. 1987; Rosen P.P., Groshen S. et al. 1989; Elston 
C.W. and I.O. 1991; Fisher E.R., Anderson S. et al. 1993; Nixon A.J., Schnitt S.J. et al. 
1996; Goldhirsch A., Glick J.H. et al. 1998). The combination of histological type and 
grade provide a more accurate assessment of prognosis than does histological type 
alone(Pereira H., Pinder S.E. et al. 1995).. Histological grade may also provide useful 
information with regard to response to chemotherapy and, therefore, be a predictive 
factor as well as a prognostic indicator.  
Receptor status 
Actually, three important receptors, taken together with other predictive factors, 
contribute to prognosticate the patient’s clinical outcome. These are the steroid 
hormone receptors for oestrogen (Oestrogen receptor, ER) and progesterone 
(Progesterone receptor, PR); and the Human Epidermal Growth Factor Receptor 2 ( 
HER2/neu ) 
Oestrogen receptor (ER) and Progesterone receptor PR 
Oestrogen is an important mitogen exerting its activity by binding to its receptor (ER). 
Approximately 60% of breast carcinomas express the ER protein. Initially, ER-positive 
tumours were associated with an improved prognosis, but studies with long-term 
follow-up have suggested that ER-positive tumours, despite having a slower growth 
rate, do not have a lower metastatic potential. Nonetheless, ER status remains very 
useful in predicting the response to adjuvant tamoxifen (Anon. 1992; Osborne C.K. 
1998; Isaacs C., Stearns V. et al. 2001). PR is a surrogate marker of a functional ER. In 
oestrogen target tissues, oestrogen treatment induces PR. Both can be detected by 
ligand binding assay, or more commonly nowadays, by immunohistochemical (IHC) 
analysis using monoclonal antibodies. ER/PR-positive tumours have a 60-70% 
response rate compared to less than 10% for ER/PRnegative tumours. ER-positive/PR-
negative tumours have an intermediate response of approximately 40%. The impact of 
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hormone receptor status on prognosis and treatment outcome prediction is complex, 
nevertheless, measurement of both ER and PR has been clinical practice for more than 
20 years. 
The Human Epidermal Growth Factor Receptor 2 (HER2/neu) 
The ERBB2 gene, which codify HER2 receptor has been shown to play an role in the 
pathogenesis and progression of certain aggressive types of breast cancer and it is 
evolving to become an important biomarker and target of therapy. Amplification of the 
HER-2/neu gene is a significant predictor of both overall survival and time to relapse in 
patients with breast cancer. (Slamon D.J., Clark G. M. et al. 1987) 
Molecular classification 
Clinical-pathological information described above, such as the histological type, grade, 
tumour size, lymph-node involvement represents the current standard to estimate a 
patient’s likelihood for recurrence and assess the right prognosis (Andre F. and L. 
2006) nevertheless tumours characterised by similar histopatological features could 
present significantly different outcome and treatment responsiveness. Despite the great 
advances that have been made in breast cancer therapy, still the major challenge is to 
exactly determine which patients are most likely to benefit from which therapies and in 
identifying subgroups of patients who are at the highest risk for recurrence.  
Breast cancers phenotypic diversity could be explained by diversity in gene expression 
(Perou C.M. 2000). A large number of genetic alterations have been identified in 
invasive breast carcinomas, many of which are of potential prognostic or predictive 
value. Some provide treatment–independent information on patient survival, others 
predict the likelihood that a patient will benefit from a certain therapy. Some alterations 
may have both prognostic and predictive value (Tavassoli F. A. 2003). 
In the last decade, the gene expression profiling improved the classification of breast 
cancer: several microarray analyses on breast cancers have identified gene expression 
profiles able to separate tumour classes associated with patient survival with 
implications for prognosis and drive therapy as specifically as possible.  
Perou et al. (Perou C.M. 2000) and Sorlie et al.(Sorlie T., Perou C.M. et al. 2001) 
showed that the expression profiles primarily distinguished ER+ from ER- tumors. 
They called them luminal and basal subtypes because of their respective luminal and 
basal characteristics. In particular, Perou and colleagues characterized the variations in 
gene expression patterns in a set of 65 surgical specimens of human breast tumours 
from 42 different individuals, using complementary DNA microarrays representing 
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8,102 human genes. These patterns provided a distinctive molecular portrait of each 
tumour and were able to identify four groups of breast cancers that might be related to 
different molecular features of mammary epithelial biology. These four groups were as 
follows:  
1. normal breast like;.  
2. luminal cell like tumours, expressing oestrogen receptor (ER+) and showing 
similar profiles to those of normal luminal cells of breast gland;  
3. basal cell-like (BCL) or ‘triple negative’ phenotype (ER-, PR- and HER2- ) 
associated with aggressive behaviour, poor clinical outcomes, lack of response 
to the usual endocrine therapies and shorter;  
4. finally Erb-B2 tumors, negative for estrogen receptor as BCL subtype but with 
overexpresion of the HER2) (Perou C.M. 2000; Sotiriou C. 2003; Liu H. 2008) 
 
Another microarray-based analysis by Sorlie and collagues (Sorlie T., Perou C.M. et al. 
2001), confirmed the previous results of Perou et al. and segregated further tumours 
into distinct subgroups mainly based on their luminal (ER+) and basal (ER-) 
characteristics. In this case the luminal-like tumours were further segregated into at 
least two (possibly three) smaller subgroups, which correspond to luminal A, B, and C 
subtypes.  
Although the luminal A subtype showed a favourable clinical outcome when compared 
with other luminal subtypes, this difference was not statistically significant. However, 
luminal A tumours were shown to be strongly associated with good prognosis an a less 
aggressive behaviour also when compared with the BCL or Her2/neu groups (Sotiriou 
C. 2003).  
An important implication of this study is that the clinical designation of `estrogen 
receptor negative' breast carcinoma encompasses at least two biologically distinct 
subtypes of tumours (basal-like and ErB-B2 positive), which may need to be treated as 
distinct diseases. Furthermore it has been found that a metastasis and primary tumour 
were as similar in their overall pattern of gene expression as were repeated samplings 
of the same primary tumour, suggesting that the molecular program of a primary 
tumour may generally be retained in its metastases. A deeper characterization to define 
the portraits of each tumour and the correct interpretion of their patterns of variation, 
could undoubtedly lead to a deeper and more complete understanding of breast cancers 
(Perou C.M. 2000; Sotiriou C. 2003).  More precisely, the accurate  prognostic 
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signatures can identify patients with good or poor survival rate and can drive to the 
more efficient individual therapy. 
1.3 Cancer and biomechanical properties 
1.3.1 Biomechanical properties alteration in cancer cells  
The biophysics of cells in human diseases is emerging as a topic of rapidly expanding 
scientific interest. In particular in the past decade, the interest on the correlation 
between the  biophysical properties of cells and the onset and progression of cancer has 
significantly increased (Suresh 2007). The well known genetic and molecular 
alterations that characterize cells cancer can not completely explain alone the complex 
process of malignant transformation and invasion; therefore cancer biologists have 
begun to recognize that a critical component of the neoplastic transformation process 
involves marked alterations in the mechanical phenotype of the cell and its surrounding 
microenvironment (Kumar and Weaver 2009).  
During  progression, cells undergo from a fully mature, post mitotic state to a 
replicating, motile and immortal cancerous cell and the cytoskeleton devolves from a 
rather ordered to a rigid structure as well as to a more irregular and compliant state. 
These changes influence  the overall mechanical properties. Therefore, the 
biomechanical properties (rigidity, elasticity, deformability) of malignant cells (usually  
marked by high replication and motility) can  provide useful information about their 
state and they can  be viewed as a new biological markers, which  offer an alternative 
identification to current proteomic techniques (Guck J. 2005) . 
It has been demonstrated that even though tumours are relatively stiff (due to their 
ECM), the tumour cells themselves are softer in comparison to their normal counterpart 
(Lincoln B., Erickson H.M. et al. 2004; Guck J. 2005; Suresh 2007) and hence they are 
able to move and spread through dense ECM suggesting a continuous biomechanical 
interaction between the cells and their ECM leading to the adaptation of the cell 
motility (Huang H. 2005). 
Following this hypothesis, in the last decades several groups tried to discriminate 
cancerous and non cancerous cells by mechanical analysis. 
Lekka et al. used the atomic force microscope (AFM) to study the elasticity of normal 
human bladder epithelial cells and cancerous ones by performing AFM indentation 
experiments (Lekka M., Laidler P. et al. 1999). Normal cells risulted an order of 
magnitude stiffer than cancer cells and this was attributed to the reorganization of the 
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cytoskeleton. With the same technique, Park and colleagues (Park S., Koch D. et al. 
2005) compared the mechanical properties of normal and transformed mouse fibroblast 
cells, demonstrating that fibroblast cells were stiffer than their transformed 
counterparts.  
In 2007 Gimzewki and co-workers (Cross S., Jin Y.S. et al. 2007) reported on the 
stiffness of live metastatic cancer cells taken from the body (pleural) fluids of patients 
with suspected lung, breast and pancreas cancer. Within the same sample, they found 
that the cell stiffness of metastatic cancer cells was more than 70% softer than the 
benign cells, which line the body cavity as indicated by the elastic modulus. The elastic 
moduli for the benign cells exhibited a wider variation with a log-normal distribution, 
whereas the malignant cells displayed a much narrower normal distribution of elastic 
stiffness. Different cancer types were found to display a common stiffness. 
On the same trend many other works in the last decades  (Thoumine 1997; Lekka M., 
Laidler P. et al. 1999)  confirmed evident differences in the mechanical properties 
among cancer and non- cancer cells(Ward K.A., Li W.I. et al. 1991; Zhang G., Long M. 
et al. 2002). 
Thus, the hypothesis that cellular biomechanics could help in explaining tumour 
genesis and cancer invasion (Geiger J. 2005; Makale 2007).  
1.3.2 Microrheological approaches for local investigation of cell biomechanics  
Rheology is the study of deformation and flow of material in response to forces. 
Rheological studies on cells and tissues have a long history at the intersection of cell 
biology, cell physiology and biophysics (Heidemann S.R. and Wirtz D. 2004)  
The first publications on cellular rheology were often soundly mathematical, with 
methodologies unusual to biologists, investigating the cell and its components as 
nonliving materials.  
Viscoelastic properties of materials, their relative stiffness, their resistance to both fluid 
flow and solid deformation, are dynamically regulated by the cell and also depend 
sensitively on the details related to the measurement (speed, magnitude and force of the 
measurement) (Heidemann S.R. and Wirtz D. 2004) This is the reason why new 
mathematical models are needed to characterize mechanical properties of living 
materials. In recent years, rheology gave a large contribution to cell biology and the 
interest in this research area is rapidly expanding among scientific community. 
Recently, a number of techniques have been developed to probe the material properties 
of systems ranging from polymer solutions to the interior of living cells on microscopic 
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scales. These techniques are referred as microrheology, since they can be used to 
locally measure viscoelastic parameters. The strongest motivations for such 
developments is the prospect of being able to study inhomogeneity (MacKintosh and 
Schmidt 1999), which is characteristic of biological samples. 
At the moment a wide variety of experimental biophysical techniques are commonly 
used to extract both local and global mechanical properties of living cells such as 
microplate stretcher (Hochmuth M. R. 1996; Thoumine 1997; Hochmuth 2000), 
micropipette aspiration (Hochmuth 2000) or, more recently, the AFM (Radmacher 
1996; Rotsch C. and Radmacher M. 2000; Cross 2007). Other researchers have 
employed magnetic bead rheology, (Wang N., Butler J. P. et al. 1993; Choquet 1997; 
Shures 2007), microneedle probes (Zahalak G. I., McConnaughey W.B. et al. 1990), 
acoustic microscopes (Kundu T., Bereiter-Hahn J. et al. 2000), sorting in 
microfabricated sieves (Carlson R. H. G., Gabel C.V. et al. 1997), the manipulation of 
beads attached to cells with OT (Sleep, optical et al.) (Choquet 1997; Guck J. 2005; 
Allioux-Guerin 2009; Remmerbach 2009) and MOS (Guck J., Ananthakrishnan R. et 
al. 2001). As a general rule, malignant cells responded either less elastic (softer) or less 
viscous (less resistant to flow) to stresses applied, depending on the measurement 
technique and the model employed. Metastatic cancer cells have been found to display 
an even lower resistance to deformation (Raz A. and Geiger B. 1982; Guck J. 2005).  
1.3.3 Biomechanics in breast cancer research 
The described trend of mechanical alterations in cancer cells in general has been 
observed  also for breast cancer cells, both when using cell lines (Guck J. 2005; Li 
Q.S., Lee G.Y.H. et al. 2008) or primary cells cultures (Cross 2007). For instance, 
Lincoln et al. were the first to investigate the deformability of non-malignant and 
malignant human breast epithelial cells using the MOS and they found that malignant 
cells can stretch about five times more than their non-malignant counterparts (Lincoln 
B., Erickson H.M. et al. 2004; Guck J. 2005)  
In a study of 2008, malignant (MCF-7) breast cells were found to have an apparent 
Young’s modulus significantly lower (1.4–1.8 times) than their non-malignant (MCF- 
10A). Both confocal and AFM images showed a significant difference in the 
organization of their sub-membrane actin structures, which directly contribute to their 
difference in cell elasticity (Li Q.S., Lee G.Y.H. et al. 2008).  
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Beyond the mechanical alterations characterizing the single tumoral cells, the whole 
mammary gland tissue runs into dramatic changes at the macroscopic level during 
breast cancer progression. 
The matrix of normal resting mammary gland is highly compliant but does become 
progressively stiffer during malignant transformation (Krouskop T.A., Wheeler T.M. et 
al. 1998; Plewes D.B., Bishop J. et al. 2000) there is a chronic increase in mammary 
gland tension that is linked to elevated compression force and tensile stress. The tissue 
homeostasis is not more maintained and the three dimensional architecture of the 
mammary gland is disrupted.  
Transformed malignant epithelial cells residing within the ductal tree or in the 
expanding fibrotic tumour mass experience a compression stress, furthermore the 
surrounding tissue, that is a mechanical elastic solid, is not passive and respond to the 
tumour generated compression force by exerting a reciprocal force on the expanding 
tumour mass.  
This process is described more in detail in fig.1.5: A, B describe the transformation 
event characterized by the acquisition of genetic alterations and the induction of 
proliferation in luminal epithelial cells, residing within the mammary ducts. C,D 
illustrate the proliferating pre-malignant luminal epithelial cells in the ducts exerting 
compression forces (solid stress) of increasing magnitude on the basement membrane 
and adjacent myoepithelium. In parallel, the infiltrating immune cells and activated 
resident fibroblasts induce a desmoplastic response in the surrounding stroma. The 
desmoplastic stroma is characterized by transdifferentiation of resident fibroblasts and 
changes in the interstitial matrix that include alterations in extracellular matrix 
composition, cross-linking and collagen and elastin reorientation. This  manifest as an 
increase in stromal extracellular matrix stiffness. As malignancy progresses, the 
transformed epithelium continues to proliferate, exerting chronic incremental outward 
directed compression forces (solid stress) on the basement membrane, the 
myoepithelium and the surrounding stromal tissue. The outward projecting solid stress 
is countered by a reciprocal resistance force exerted by the stromal tissue that is 
proportional to the magnitude of the tumor-derived compression force and the elastic 
modulus of the stroma. Because the desmoplastic tissue is stiffer than normal tissue the 
transformed stroma will have a greater elastic modulus and hence exert larger 
resistance forces against the expanding tumor mass. The combination of these multiple 
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tensional stresses act upon the genetically aberrant malignant cells by stimulating 
signalling cascades to induce their growth and invasion into the interstitial tissue. 
 
Fig.1.5: Tensional force and the normal and malignant breast 
Cartoon highlighting the predicted types of tensional force that a normal and malignant breast might be 
expected to experience. A, B transformation event C,D proliferating pre-malignant luminal epithelial 
cells in the ducts exerting compression forces. The infiltrating immune cells and activated resident 
fibroblasts induce a desmoplastic response in the surrounding stroma. Adapted from (Paszek M.J. and 
Weaver V.M. 2004) 
Experimental data suggest that this reciprocal tissue resistance can mediate cytoskeletal 
tensional forces and thus alter the behaviour of the tumor (cells growth, survival, 
motility and invasion) by regulating the activity of various biochemical signalling 
cascades. This forces can alter the conformations of proteins at the focal adhesions 
level, induce changes in the lipid packing in the membrane(Gilmore A.P. and Burridge 
K. 1995; Carrion-Vazquez M., Orr A.W. et al. 1999) and induce dynamic and random 
changes in the whole cellular cytoskeleton (Davies P.F. 1995; Helmke B.P. and Davies 
P.F. 2002). 
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For this reasons characterizing the mechanical properties of malignant cells in 
connection with the membrane and cytoskeleton organization is challenging for a 
deeper comprehension of the metastatic spreading process. 
1.4 Aim of the study 
The clinical, pathological and molecular classifiers of breast cancer are  used to predict 
the progression of the disease and to assign the right therapeutic approach. 
Nevertheless, patients with the same cancer, in terms of subtype, stage and grade could 
present completely different clinical outcomes. Some patients recur and some do not. 
This dichotomy requires new tools able to better characterise each patient. Cancer cell 
mechanics is emerging as a topic of rapidly expanding scientific interest, since it 
represents an innovative approach to study this kind of disease. At the moment a wide 
variety of experimental biophysical techniques are commonly used to extract both local 
and global mechanical properties of living cells: in general, malignant cells respond 
either less elastic or less viscous to applied stresses, an even oppose lower resistance to 
deformation (Raz A. and Geiger B. 1982; Guck J. 2005) These tools are able to 
discriminate between cancerous and non cancerous cells. 
The aim of this study was to investigate in vitro the mechanical and molecular 
properties of different cell lines related to different stages of breast cancer 
aggressiveness, using three different biophysical micromanipulation tools: Optical 
Tweezers, Atomic Force Microscopy and Microfluidic Optical Stretcher. Up to now, 
most of the studies related to the biomechanical properties of diseased cells have 
compared mechanical properties of tumour cells versus to normal ones or non-
transformed cells (Lekka M., Laidler P. et al. 1999; Zhang G., Long M. et al. 2002; 
Guck J. 2005; Park S., Koch D. et al. 2005). In this thesis we investigated if 
biomechanical tools are able to sense the different stages of aggressiveness of breast 
cancer cells. To fulfil our proposal, we chose the cell line model for luminal A tumours, 
MCF-7, and basal tumours of the breast, MDA-MB-231. To compare our results and to 
investigate the reliability of our approaches we selected as model for normal cells the 
cell line HBL-100, which was developed from milk of 27-year-old Caucasian woman 
with no evidence of breast cancer lesions. Finally, we investigated on the actin 
cytoskeleton organization of cells by STimulation Emission Delpetion (STED) and 
confocal microscopy; and analyzed cell membranes lipid composition by MALDI Mass 
Spectroscopy (MALDI-MS). The aim was to associate the biomechanical analysis on 
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cells and their plasma membranes to possible alterations of cytoskeleton structure and 
membranes lipid composition. 
26
 
 
 
2. MATERIALS AND METHODS 
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2.1 Cell Cultures 
2.1.1 Cell lines description  
According to the molecular classification described by Perou and colleagues (Perou 
C.M. 2000) (see section 1.2.2.5) two breast cancer cell lines from two different groups 
related to different aggressive behaviours were selected: MDA-MB-231 and MCF-7 
cell lines. Finally a third breast cell line, HBL-100, which is immortalized but non-
neoplastic was analyzed. These three immortal cell lines were used as model of human 
epithelial cells progressing toward malignancy.  
Briefly, MDA-MB-231 (Fig 2.1, left) is an estrogen receptor independent breast cancer 
epithelial cell line derived from the pleural effusion of a cancer patient. It is widely 
used for breast cancer biology studies; it belongs to the Basal cell-like (BCL) or “triple 
negative” phenotype. As already described in section 1.2.2.5, this subtype has been 
associated with aggressive behaviour, poor clinical outcomes, lack of response to the 
usual endocrine therapies and shorter survivals when compared to other cancer 
subtypes. (Perou C.M. 2000; Foulkes WD 2003; Sotiriou C. 2003; Liu H. 2008) We 
used this cell type as a model of tumoral cell with high aggressive behaviour. 
MCF-7 (Fig 2.1, central picture) is an estrogen receptor dependent breast cancer 
epithelial cell line widely used for studies of breast cancer biology and hormone 
mechanism of action. The cell line was originally derived at the Michigan Cancer 
Foundation from a malignant pleural effusion from a postmenopausal woman with 
metastatic breast cancer, who had been previously treated with radiation therapy and 
hormonal manipulation (Soule H., Vazquez J. et al. 1973). The cells express receptors 
for a variety of hormones including estrogen, androgen, progesterone, glucocorticoids, 
insulin, epidermal growth factor, insulin like growth factor, prolactin, and thyroid 
hormone (Lippman M., Osborne C. et al. 1977). It  belongs to Luminal A cell-like 
tumour subtype which is associated with good prognosis and a less aggressive 
behaviour,  compared to the BLC group (Sotiriou C. 2003) 
Finally, HBL-100 (Fig 2.1, right) is an epithelial cell line developed and established in 
vitro, obtainedfrom the milk of an apparently healthy 27-year-old Caucasian woman 
after 3days from delivery (Polanowski F.P., Gaffney  E.V. et al. 1976; Gaffney E.V. 
1982). The milk donor was followed for several years with clinical and mammographic 
evaluations at regular intervals with no detectable breast lesion (Gaffney E.V. 1982; 
Ziche M. and Gullino P. 1982).  
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Figure 2.1: Optical Microscope image of the three cell lines. 
Optical microscope image of the cell lines MDA-MB-231(left) MCF-7(centre) and HBL-100 (right) on 
adhesion on a Petri dish. Scale bar is 25µm. 
Cell lines MDA-MB-231 and MCF-7 were kindly provided by Dr. Licio Collavin from 
the Molecular Oncology Unit at L.N.CIB, AREA Science Park (Trieste, Italy); cell line 
HBL-100 was kindly provided by Prof. Giuliana Decorti from the Biomedical Science 
Department at University of Trieste. 
2.1.2 Cell cultures propagation and passaging 
MDA-MB-231 and MCF-7, were cultured on adhesion and maintained in low glucose 
Dulbecco’s modified eagle’s medium (DMEM) with L-glutamine (Euroclone); HBL-
100 were grown and mantained in RPMI 1640 medium with Stable L-glutamine 
(Euroclone). The culture mediums were used including 10% fetal bovine serum (FBS), 
50 IU/mL of penicillin-streptomycin solution and 1mM Gentamicyn. Cell cultures were 
kept in an incubator at 37oC with 5% of CO2. 
Cell passaging was performed with the same protocol for each cell type: adherent cells 
were incubated at 37oC with a 1:10 diluited solution of 0,05% Trypsin/EDTA using a 
proper volume to cover the entire flask’s surface: trypsin solution was incubated for 3-4 
minutes until the cells detachment from the flask surface. Afterwards trypsin action was 
blocked by adding 1 mL of cell culture medium containing FBS (FBS contains alpha-1-
antitrypsin which inhibits trypsin). The solution with cells in suspension was then 
removed from the flask, collected in a Falcon tube and centrifuged at 800 rpm for 4 
mins. Cell pellet was resuspended in new warm medium, cells were counted in a 
Burker cell counting chamber and plated in new flasks in a proper concentration. 
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2.2 Methods used for local measurements of biomechanical properties of 
single cells 
Among the variety of experimental biophysical probes that are currently used to extract 
mechanical properties of cancer cells, we chose the following approaches: Optical 
Tweezers (OT), Atomic Force Microscopy (AFM), and Microfluidic Optical Stretcher 
(MOS). 
By OT, an optically trapped bead was used to grab the plasma membrane and pull a 
tether of several microns to measure the viscoelastic properties of the cell membrane. 
We measured tether stiffness, membrane bending rigidity and cell viscosity. A bead 
glued on the tip of the cantilever was used to locally indent the cell and measure the 
Young’s Modulus. With both these approaches, OT and AFM, we were able to perform 
very local measurements and to test the mechanical properties of the cell membrane as 
well as the underlying region. OT tether membrane approach gives viscoelastic 
informations about cytoskeleton-membrane interaction (tether stiffness and viscosity, 
rupture force, membrane bending) while AFM gives elastic information about a larger 
region of the cell under bead indentation. 
Cell detached from substrate and flowed in a microfluidic channel were trapped and 
stretched by two counter propagating laser beams by MOS. The deformation of the 
cells stretched by the radiation pressure of light was used as biomechanical parameter 
characterizing the cell as a whole body. 
In conclusion, using three different approaches, we could evaluate different mechanical 
properties of a cell region or cell as a whole. The principles, the setups, and the 
experimental approaches are described in the following sections. 
2.2.1 Locally membrane probing of the viscoelastic properties by Optical 
Tweezers (OT)  
2.2.1.1 OT principle and applications to cell biomechanics 
In 1970, Arthur Ashkin proved experimentally that micron-sized particles could be 
accelerated and trapped in stable optical potential wells, using only the force of 
radiation pressure from two counter propagating Gaussian beams (Ashkin A. 1970)  
The single gradient beam, or Optical Tweezers, was demonstrated for stable three-
dimensional trapping of dielectric particles by the same group in 1986 (Ashkin A., 
Dziedzic J.M. et al. 1986). Soon after, they demonstrated that viruses and bacteria 
could be trapped and manipulated without optical damage (Ashkin A. and Dziedzic JM. 
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1987). Then OT was used by Ashkin and colleagues to measure force generated by 
organelles transport (Ashkin A., Schutze K. et al. 1990) and by Block et al. to measure 
forces developed by single kinesin molecules (Block A.M., B. et al. 1990). 
Since then the OT has rapidly developed in many different research areas such as 
biology, physics and chemistry (Ashkin A. 2006) and its success is rapidly increasing. 
This technique has proven to be effective because laser-based optical traps can 
precisely isolate and trap dielectric spheres, viruses, bacteria, living cells, organelles, 
small metal particles, and even strands of DNA. Two of the main uses in force 
spectroscopy have been the study of molecular motors and the physical properties of 
DNA. The use of OT to probe mechanical properties of larger structures such as cells 
and membranes has been increasing in the last decade. As technique for cell mechanics 
OT present several advantages:  
1-probing by individual beads can be monitored in different regions of the cell;  
2-measurements can be very local and occur over brief periods of time;  
3- it probes the mechanics of the underlying cytoplasm or test the local viscoelastic 
properties of cell membranes (Sheetz M.P. and 2001) 
The advantage of using OT in biological samples  lies on the “contact-free” and lack of 
sample photodamage, by using a laser at wavelengths for which absorption of the 
biological matter is low. The typical wavelength used for biological applications is 
around 1 μm (infrared light), for which viability tests on cells have been made both on 
bacteria and eukaryotic cells (Neuman K.C., Chadd E.H. et al. 1999; Ericsson M., 
Hanstorp D. et al. 2000). Furthermore OT can be easily built on standard optical 
microscopes and do not need an extremely complex technology neither high costs. 
A schematic represantation of the OT microscope is shown in Fig 2.2, left . The laser 
beam is focused by a microscope objective into the sample cell. Small particles 
diffusing in the fluid of the sample cell are confined toward the focus and trapped by 
the forces exerted by the laser beam. A high numerical aperture (NA) objective is 
necessary to obtain a 3D optical trapping. Low NA (NA< 0.9) allow only a 2D trapping 
confining the particles along the optical axis.  
The trapping force (see Fig 2.2) is proportional to the laser power (W) , the refractive 
index of the medium ( nm) and a dimensionless efficiency coefficient (Q) which 
depends on the trapped object (shape and refractive index). 
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Figure 2.2: Schematic view of an optical trap.  
(left) Represented in pink, a laser beam  is reflected by a dichroic mirror and directed to an objective 
lens. Objective lens focus the laser and create an optical trap. The image system is indicated in green: 
white light crosses the objective lens, the dichroic mirror and continue its path to a camera (not shown) 
for the experiment videotracking. A particle  is optically trapped. (right))The trapping force is 
proportional to the laser power (W) , the refractive index of the medium (nm) and a dimensionless 
efficiency coefficient (Q) which depends on the trapped object . 
To explain the 3D optical trapping mechanism, a simple explanation can be given for 
macroscopic spherical particles considering ray optics propagation and conservation of 
light momentum (Ashkin A., Dziedzic J.M. et al. 1986). A ray of light bends due to 
refraction through the bead, and hence the light linear momentum associated to the ray 
changes, as shown in Fig. 2.3 below. The change of light momentum P is transferred to 
the bead as force F.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3: Force exerted by a ray of 
light on a spherical particle, as a 
consequence of the light momentum 
conservationchange of light momentum 
due to ray bending by refraction.
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The directions of the resultant force exerted on the bead by two rays of a strongly 
focused beam is shown in Figure. 2.4 for three typical situations: on axis after and 
before the focus and out of axis. It can be seen that, for sufficiently high beam 
convergence angles, one expects a strong backward gradient component of the radiation 
pressure force.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The trapping mechanism for smaller submicrometer Rayleigh particles, can not be 
explained by the ray optics approach presented above. Optical trapping of particles as 
small as 30 nm has been demonstrated (Neuman K.C. and Block M. 2004). The 
trapping mechanism and the forces acting on such small particles can be derived 
considering the polarizability of the particle and the dipole induced by the gradient of 
light intensity (Ashkin A. 2006). 
Figure 2.4:  
 
Ray optics explanation of the stability of a tweezer trap for 
spherical particles large compared to the wavelength of the 
laser beam λ, for different displacements of the sphere 
relative to the beam focus at f.  
Note the origin of the so-called "backward radiation 
pressure" in (a), which pulls the bead to the focus when the 
bead is on the optical axis after the focus.  
If the bead is after the focus (b) the bead is pushed to the 
focus.When a bead is situated out of the optical axis (c) the 
resultant force pushes the bead to optical axis. 
Taken  from (Ashkin A. 1992) 
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The explanation of the trapping mechanism above presented is pictorial and helps 
understanding optical trapping. However, it does not completely characterize the 
behaviour of the optical trap. The optical force is not the only force exerted on the 
trapped particle. A micrometer sized bead in water has an extremely low Reynolds 
number, which means that inertial forces play a negligible role in the bead's motion. 
The mass of such beads is tiny and their density often similar to that of water, so that, 
over short timescales at least, we can also disregard gravitational force. This means we 
need only to consider the following forces acting on a trapped object (see figure 2.5): 
- Restoring force due to the optical trap:Fr = κ·xwherexis the displacement from the 
centre of the trap and κ is the trap stiffness. 
- Drag force due to the viscosity of the medium: Fd=γ(dx/dt) where γ is the drag 
coefficient and dx/dt is the velocity. 
- Thermal forces (Ft) due to thermal energy (kBT). This force varies randomly and 
results in the so called thermal or Brownian motion of the object. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The forces acting on a freely diffusing but trapped particle at any moment can then be 
described by the equation: 
Ft =Fr+Fd= κ·x + γ(dx/dt)       (eq.2.1) 
Fig. 2.5: Forces in an optical trap  
(a) Schematic of a 1 μm bead diffusing in an optical trap. The bead's position is monitored with a 
detector, shown schematically above the trap. The forces acting on the bead are the restoring force 
due to the optical trap, stiffness κ; the viscous drag force on the bead, drag coefficient γ; and thermal 
forces due to the mean thermal energy (kBT/2). (b) Mechanical model of the forces acting on the 
bead. The spring represents the restoring force due to the trap stiffness; the dashpot the damping due 
to viscous drag; and the arrows the random forces due to thermal energy. Taken from 
http://www2.bioch.ox.ac.uk/~oubsu/ebjknight/motion.html) 
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Optical tweezers have the useful property that the restoring force is linearly 
proportional to displacement (at least over positions near to zero). This linearity means 
that the strength of the trap can be represented simply by a stiffness value. We can also 
say, the trap is analogous to a simple spring i.e., it obeys Hooke's law. This linear or 
Hookean behaviour is one of the most useful properties of OT. As well as providing an 
obvious way of measuring very small forces, it simplifies the mathematical properties 
of the system, as described below.  
Because the restoring force is proportional to displacement (F = κ·x) and the work done 
to displace an object from the centre of the trap is given by E=F·x/2, then the potential 
energy of an object is given by E= κ·x2/2. This results in what is often described as a 
parabolic “potential well”. The mean thermal energy of an object is kBT/2per degree of 
freedom, where kB is Boltzmann's constant (1.4×10-23J·K-1), and T is the absolute 
temperature. At room temperature, kBT ≈ 4 pN·nm (1 pN·nm = 1zeptojoule or 10-21J). 
However, the actual distribution of energy is exponential: 
P=e-E/kBT         (eq.2.2) 
(Boltzmann's law). This, together with the parabolic potential well, means that the 
distribution of positions over time tends to follow a Gaussian or normal distribution. 
Thus, if we observe a trapped object for long enough and record its position, then if we 
plot a histogram of positions it forms a Gaussian shape with a width determined by the 
temperature and trap stiffness. In fact, the variance <x2> of the position signal is given 
bykBT/κ. In other words, if we know the temperature, we can use the variance as a 
measure of stiffness:  
κ=kBT/<x2>         (eq. 2.3) 
There are also other methods to calculate the trap stiffness. Two examples are the 
power spectra (Berg-Sorensen K. and Flyvbjerg H. 2004) and the Stokes drag (Singer 
W., Bernet S. et al. 2000) methods. However, for these methods, the viscosity of the 
solution of the trapped particle needs to be known. Since the culture of the cells is 
characterized by considerable viscosity fluctuations, impossible to be measured 
accurately, we have chosen equipartition method. 
2.2.1.2 Custom built OT set up  
We have built the custom inverted OT setup shown in Fig 2.6. 
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Figure 2.6: OT setup for force-elongation measurements.  
The trapping IR laser beam is focused by the microscope objective to form an optical trap inside the 
sample cell (Petri-dish). The approached cell is observed in transmission by imaging it on the CMOS 
camera. The XYZ movement of the stage on which the Petri-dish is fixed, sample temperature, sample 
illumination, laser power, and sample imaging are remotely controlled. Taken from Tavano F. et al. 2011 
The trapping laser beam is generated by a 1024 nm continuous wave single mode Yb 
fiber laser (YLM-5, IPG Photonics GmbH). The laser head has a built-in collimator 
providing a TEM00 collimated beam with the diameter Db= 5 mm. Since the entrance 
pupil of the microscope lens (Olympus, 100X, NA 1, WD 1) has a diameter Dp = 3.6 
mm, the laser beam overfills it, meeting the condition for an optimum trapping. The 
objective lens has a moderate numerical aperture (NA = 1, water immersion) which still 
provides a stable three-dimensional (3D) trapping. In turn, it has a relative long 
working distance (WD= 1 mm), allowing to move the trapped particle axially for 
hundreds of microns inside the sample cell. The alignment of the IR trapping beam is 
facilitated by a red guide laser beam (660 nm, 0.5 mW), emitted by the same source. 
Powers higher than 20 mW are necessary at the microbead location to obtain a stiff 
trap. Typically, the IR laser power at the output of the collimation head is regulated 
from 250 to 800 mW, allowing a trap stiffness kOT > 0.1 pN/nm. The microbead is 
imaged by microscope objective and the tube lens on the sensor of the high speed 
CMOS camera (Fastec HiSpec-4, Adv. Im. Syst.) providing an acquisition velocity 
from 523 frames per second at full resolution (1696 x 1700 pixels) to 80 kfps at 
reduced resolution (128 x128 pixels). Note that the tube lens has a focal length (f= 300 
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mm) longer than the tube lens of a corresponding Olympus microscope (f= 180 mm). 
This allows an effective magnification, M= 167 X, higher than the nominal 
magnification (100X) allowed by the microscope objective with a normal tube lens. 
This longer focal length provides a better position detection sensitivity during 
microbead videotracking in the trap. Videotracking has been performed using the 
Particle Detector and Tracking Plugin of the open access NIH Software ImageJ 
(http://rsweb.nih.gov/ij/index.html). The plugin is based on an algorithm (Sbalzarini 
2005) developed at ETH, Zurich, Switzerland and permits to follow the position of the 
microbead with a precision of about 5 nm. Videotracking calibration has been 
performed separately using stuck beads on coverslip and a 3-axis piezo–stage 
(Max314/M, Thorlabs/Optoprim). The movement of the sample during the experiments 
with the cells in vitro is instead carried out by a 3-axis DC motor stage with equipped 
with high resolution encoder (M-111 XYZ, Physik Instrumente PI) allowing 15 mm 
linear motion for each axis. This choice is required by the experimental working 
conditions where cell has to be quickly identified in a field of 12 mm in diameter 
 
Figure 2.7: Picture of the custom-built OT setup 
Partial picture of the setup, showing the sample cell environment. Components indicated: the temperature 
controlled stage, composed by a film resistance inserted in a ring of aluminium and a temperature sensor; 
the microscope objective is oriented toward the sample cell in an inverted microscope configuration; 
motorized stage XYZ. Taken from Tavano F., et al 2011 
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2.2.1.3.Cells preparation and beads functionalization  
One day prior the OT experiments cells were plated on slightly modified Petri-dishes. 
We drilled a hole of 12 mm diameter in each Petri-dish and replaced the plastic by a 
glass 170 µm thick coverslip. This allowed a better propagation of the trapping beam 
and at the same time, the possibility to work also with microscope lenses with short 
WD. In order to have an adequate number of cells during experiments, 15-20x104 cells 
were seeded in a modified Petri-dish. To have uniformity in the experimental 
conditions 18 hours prior to experiments, Ara-C was added in the cell medium to a 
final concentration of 5um, in order to arrest cell cycle in the S-phase and perform the 
tether pulling experiments on cells in the same cell cycle phase.  
During experiments, Petri-dish settled on a home made heating insert and kept at 37 ºC 
by a digital temperature controller (RSComponents) to maintain physiological 
conditions during experiments. There was no control of CO2 concentration in the cell 
environment thus every Petri-Dish was used not more than 20-30 minutes to avoid pH 
alteration damages. To test the mechanical properties of cells on adhesion we used 1.5 
um silica beads as probe. Beads were coated with COOH groups (Kisker-biotech, cat 
PSi- 1.5COOH) and functionalized  with Bovine Serum Albumine (BSA) using the 
PolyLink Protein Coupling Kit (Bang Laboratories Inc., cat PL01N) following the 
manufacturer’s protocol. Briefly, about 1.4 x 105 beads were incubated with 500 ng of 
BSA in the presence of 20 g L-1 EDAC (water-soluble carbodiimide) for 1h at room. 
Beads were usually prepared one or two days before the experiments and stored at 4oC 
to avoid protein degradation. With an immunofluorescence staining with anti-BSA 
antibodies we confirmed that the coating was successful: BSA was present and its 
distribution on the bead was homogeneous. 
 
 
Figure 2.8 Immunofluorescence staining of BSA functionalized (left) and non functionalized (right) 
silica beads using α-BSA antibody. The test confirmed the BSA functionalization was successful and 
BSA was homogeneously distributed on the bead surface.  
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Beads used for pulling tethers were injected with a micropipette directly on cells some 
minutes before the experiment, to give beads time to float in the medium. When beads 
reach the focus point, we could visualize and trap them. 
2.2.1.4. Tether membrane extraction and force-elongation measurement technique 
The experimental approach used to extract a membrane tether by means of OT is 
described in this section and  illustrated in Figure 2.9. 
A silica microbead coated with Bovine Serum Albumine (BSA) is trapped by the laser 
beam focused through the microscope objective (100x, water). The cell of interest, laid 
on the culture dish, is then approached to get its membrane in contact with the 
microbead (Figure 2.9a, left). This is achieved by controlled x-y-z movements of the 
motorized stage. After few seconds of contact the coated bead is supposed to bind the 
surface membrane proteins and the tether can be extracted by moving laterally the stage 
at constant velocity (0.5 µm / s ) (Figure 2.9a, centre ). The tether is a membrane tube 
like with a diameter usually about 100 nm and hence it can not be visualized. To verify 
tether formation we switch off the laser and observe the movement of the microbead. If 
the microbead rapidly retracts to the cell the presence of the tether membrane is 
confirmed (Figure 2.9a, right). If the microbead simply diffuses around, it means that 
no tether has been created and the experiment should be repeated. During tether 
formation, both the cell and the bead are monitored by a CMOS camera working at a 
high acquisition frame rate ( > 200 frames / s ). 
 
Figure 2.9 . Schematic of the experimental approach 
Above:Sequence of three pictures showing the trapped bead in contact with the cell membrane (left), the 
cell translation during tether formation (centre), the bead retraction to the cell after laser is switched off. 
The laser is marked by the red triangle. Below: the focused laser creating the optical trap is marked by 
the red triangle. The third picture on the right shows the bead retraction to the cell after laser is switched 
off. Below: Sequence of three images showing the trapped bead in contact with the cell membrane (left) 
andthe cell translation during tether formation (centre and right). The size of the small vertical arrows 
oriented downward is proportional to the displacement. Scale bar is 10 µm. 
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Measurement of weak mechanical interactions (in the range from 10-1 to 102 pN) using a 
trapped microbead as a probe is based on the fact that the force acting on a microsphere 
within an optical trap can be modelled as a Hookean spring (Svoboda K. 1994), 
provided the displacement from the optical trap is not too large:  
F=Kot*Xb         (eq.2.4) 
where kOT is the spring constant (trap stiffness) and Xb the displacement of the 
microbead. Thus, to get the force, the bead displacement Xb is measured by 
videotracking its image, which is formed on a high speed CMOS camera with high 
frame rate. The trap stiffness kOT is calculated prior to each experiment by using the 
equipartition theorem method described in 2.2.1.1  
During the pulling experiments, beside the bead displacement Xb we measured also the 
cell displacement, x(t). The calculated force is expressed as a function of elongation, 
F=F(x). The resulting plot is called Force-Elongation curve. All the FE curves have in 
common the presence of three regimes with distinct dominant behaviours: elastic, 
rupture, and viscous. A typical FE curve is shown in Figure 2.10. 
 
 
Figure 2.10: Force-elongation FE curve.  
The curve is determined by measuring the force exerted on the bead when a tether membrane is formed. 
Note the presence of three distinct regions: 1- elastic regime, 2 – detachment of the membrane from the 
cytoskeleton, 3- viscous regime. 
In the first part, the force increases almost linearly with the elongation, which is 
characteristic for an elastic regime. A maximum force is reached followed by relaxation 
in (2). This corresponds to the local separation of the membrane from the cytoskeleton. 
Finally, the force remains almost at a constant value which is characteristic for a 
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viscous behavior (3). The FE curve shown in Figure 2.10 is consistent with the 
assumption that the force necessary to pull a tether from membrane must overcome the 
membrane bending rigidity, the membrane tension membrane, the adhesion of the 
phospholipid membrane bilayer to the cytoskeleton and the viscous resistance of the 
phospholipid bilayer (Sheetz and Dai 1996; Raucher and Sheetz 1999; Sheetz, 2001). 
Forces of tens of pN are typically necessary to extract tethers (Hochmuth et al. 1996, 
Ermilov et al. 2005), which is well in the range of forces developed with OT. 
The shape of our FE curve is similar to those reported previously in literature for cancer 
cells (Guo et al. 2004), neuronal cells and other types of cells (Hochmuth et al. 1996; Li 
et al. 2002; Ermilov et al. 2005). The data analysis to extract the parameters of interest 
to describe the local viscoelastic properties of cells is described in section 3.1.1.4.  
2.2.2 Elastic modulus measurement for single cells by AFM 
2.2.2.1. The  Indentation technique  
We used AFM to perform indentation experiments and determine the Young Modulus 
corresponding to a cell region. The indentation, δ, on the cell is given by the difference 
between the piezoelectric movement z, and the tip deflection x (figure2.11, right): 
 δ= z+x         (eq.2.5) 
A bead was glued on the tip of an AFM cantilever. The cantilever was precisely moved 
down into the cell by a piezoelectric element while the deflection of the cantilever was 
measured by the laser beam deflection on the photodetector (figure 2.11, left) Both the 
deflection of the tip and the movement of the cantilever are measured with nanometer 
resolution (Franze K. 2011) 
 
 
Fig. 2.11 
(left) Cell indentation experiment with AFM. Cell is laying on adhesion while the cantilever indents cell 
surface. Deflection is measured by a laser beam reflected on the cantilever and is detect by a photodiode. 
(right) Sample indentation is described in detail: the cantilever is moved towards the sample by a 
distance z (height measured). The cantilever is bending into the opposite direction (x) whilst the sample 
is indented by δ . Finally δ is calculated by subtracting the cantilever deflection from the heigh measured. 
(jpk instruments) 
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For small deformations, the cantilever follows Hooke’s law F = kx, where F is the 
force, x is the displacement from the equilibrium position, and k is the cantilever’s 
spring constant (for biological samples usually 0.01–0.1 N/m). By recording cantilever 
deflection with higher frequency during the entire experiment, it is possible to derive 
the force during both the cantilever indentation in the cell and the cantilever retraction 
to the original position.  Forces in the piconewton range can be measured with AFM 
(Munevar S., Wang Y. et al. 2001; Franze K., Gerdelmann J. et al. 2009). The data 
obtained by indentation measurements were plots of vertical cantilever deflection 
against tip-sample separation. An example is shown in Figure 2.12. To derive the 
Young’s Modulus, the “extend” curves which relate to the indentation, but not the 
“retract” curves which relate to the retraction of the cantilever, were  fitted in the Hertz 
(Hertz H. 1881 ) model by a dedicated JPK software, as described afterward in section 
2.2.2.3. 
 
Figure 2.12: Example of curve resulting from and indentation experiment. 
Cantilever vertical deflection Vs Tip-Sample separation during the extend (red) and the retract 
(green).The “extend” curve relates to the indentation, the “retract” curve relates to the retraction of the 
bead from the cell. 
2.2.2.2 AFM setup and experimental approach 
For our analysis, we used Nanowizard II AFM (JPK, Berlin, Germany) with a silicon 
nitride cantilever, V-shaped, 100 μm long and with a nominal spring constant of 
37pN/nm from NANOWORLD (PNP-TR-TL-20). However, sharp tips exert a large 
stress s = F/A on the sample, where F is the force and A is the contact area. Thus, such 
probes are very likely to penetrate soft materials such as cell membranes and the 
underlying actin cortex already at small forces, limiting their application in biological 
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samples (Franze K. 2011) and invalidating elasticity measurements. For this reason, we 
used a bead glued on the tip of the cantilever (silica bead of 4.5 μm diameter , Kisker-
biotech). 
The cantilever was calibrated in liquid on a glass coverslip. Silica beads were first 
sonicated and a drop of 5 µl of them was dispersed on a glass coverslip. Also a drop of 
UV-curable glue was dispersed in the same glass coverslip, forming thin lines of glue 
close to the silica beads. The tipless cantilever was engaged on a clean area of the glass 
and then aligned on the top of a glue lines few microns far away from it. A force-curve 
with a set-point of 1nN and a z-length of 10 µm with a speed rate of 10 µm/s was 
performed to attach glue just on the end of the cantilever. The cantilever was then 
brought in contact with an isolated bead and a force-spectroscopy curve was obtained 
with a delay of 30 seconds between the extended and the retracted curve to permit the 
adhesion of the bead to the cantilever. Moreover a slow left-right movement was 
performed to facilitate the bead detachment from the substrate ant attachment to the 
cantilever.  
The glue was cured with direct UV exposition (using an UV lamp with a DAPI filter) 
for 30 minutes. The cantilever with the bead was firstly calibrated in liquid and then 
used to acquire force-distance curves on the patterned area. The calibration was 
repeated at least 4 times to average the sensitivity values and to obtain a more precise 
spring constant value. 
2.2.2.3. Data analysis to derive the elastic modulus: the Hertz Model 
Data analysis has been made by applying the Hertz model on curves and calculating the 
apparent sample elasticity by automatic fitting of the JPK software, which give the 
possibility to derive the Young’s Modulus (E).  
The Hertz model assumes a linearly elastic, homogeneous, isotropic material, which 
does not necessarily apply to biological samples (Franze K. and Guck J. 2010; Chatelin 
S., Constantinesco A. et al. 2011). Furthermore, this model is only valid if the 
indentation depth is 5-10% than the sample’s thickness (Engler A.J., Richert L. et al. 
2004). If the indentation depth is larger, corrections for thin samples are required 
(Dimitriadis E.K., Horkay F. et al. 2002), otherwise the Young’s modulus will be 
overestimated. Furthermore, while spherical probes provide reliable values, indenting 
cells with sharp tips results in higher Young’s moduli (Carl P. and Schillers H. 2008) 
(and probably in cell damage). Thus, Young’s moduli found in the literature should be 
interpreted with caution.  
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Nevertheless, if the experimental conditions and the data analysis are chosen carefully 
(Franze K. and Guck J. 2010; Chatelin S., Constantinesco A. et al. 2011), the Hertz 
model provides valuable information. To satisfy these conditions and to be able to use 
the Hertz model, we used a cantilever coated with a silica bead to avoid cell penetration 
and damaging; the indentation was 500 nm that can be considered neglectable 
compared to cell height. 
As already mentioned above, E was derived from force-displacement curves obtained 
with the AFM, when the deflection of the AFM cantilever was monitored as it 
approached the sample. The standard Hertz model (Hertz H. 1881 ) describes the 
indentation of a silica bead with a specified radius (R) in a soft sample, predicting that 
the force F produced was: 
 
      (eq.2.6) 
 
When the indentation δ was calculated as: 
 
         (eq.2.7) 
Where α is the half-opening angle of the AFM tip (25) and ν is the Poisson’s ratio, 
assumed to be 0.5 for cells.  
E was obtained from the best linear fit of the force-distance curve.  
2.2.3. Cell deformability measurements by Optical Stretcher (OS) 
2.2.3.1 Microfluidic Optical Stretcher (MOS) principles 
MOS is a novel laser tool which represents a recent advancement in cell manipulation 
and characterization techniques. It involves a dual-beam laser trap used to manipulate 
biological samples without mechanical contact nor bead attachment (Guck J., 
Ananthakrishnan R. et al. 2001; Lincoln B., Schinkinger S. et al. 2007). Most 
importantly, said method can be combined with a microfluidic system, which allows an 
automated serial, high-throughput measurement of the mechanical properties of cells in 
suspension (Lincoln B., Schinkinger S. et al. 2007). 
Microfluidic Optical Stretcher is based on a double-beam trap in which two opposed, 
divergent and identical laser beams with Gaussian intensity profile trap an object in the 
middle. This trapping is stable if the total force on the object is zero. The condition is 
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fulfilled if the object that is positioned in the middle of the beams has a larger refractive 
index than the refractive index of the surrounding medium.  
The principle of the OS is rather simple: when a Gaussian laser beam is incident on a 
dielectric object such as a cell, the momentum change and the resulting forces trap the 
object (figure 2.13, A) and tend to stretch it (figure 2.13, B) (Guck J., Ananthakrishnan 
R. et al. 2000). Stretching is observed as a measurable elongation of the cell along the 
laser axis. This stress is caused by a momentum transfer from the light to the interface, 
due to the change in refractive index (Ashkin A. and J.M. 1973). By increasing the 
laser power, these surface stresses can become sufficient to measurably deform a cell, 
while maintaining its position. If used for this purpose, a dual-beam laser trap is called 
an OS (Guck J., Ananthakrishnan R. et al. 2001).  
More precisely, figure 2.13 describes the distribution of surface forces (thin blue 
arrows) induced when only one laser beam with Gaussian intensity profile incides from 
one side (indicated with large triangles) for a cell which is slightly below the laser axis 
and on the axis (C,D respectively) . The integration of these forces over the entire 
surface results in the net force (Fnet) shown as larger blue arrow. When two identical 
but counter propagating laser beams incide on a cell on axis, this create a stable 
trapping configuration and it is described in figure 2.13(E). The thin blue arrows 
represent the distribution of surface forces that act on the cell and stretch it. When the 
cell is displaced from the axis as shown in figure 2.13(F), the symmetry of the resulting 
force distribution is broken, giving the net force a restoring component perpendicular to 
the laser axis.  
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Figure 2.13: Optically induced surface forces lead to trapping and stretching of cells. 
Cells flowing through a microfluidic channel can be serially trapped (A) and deformed (B) with two 
counterpropagating divergent laser beams. The distribution of surface forces (small arrows) induced by 
one laser beam with Gaussian intensity profile incident from the left (indicated with large triangles) for a 
cell that is (C) slightly below the laser axis and (D) on axis. In (E) the corresponding distributions for 
two identical but counterpropagating laser beams are shown for a cell on axis creating a stable trapping 
configuration. In (F) the broken symmetry of the resulting force distribution when the cell is displaced 
from the axis. Adapted from Guck J.2005 
Since the laser beams in the optical stretcher are divergent and not focused light, 
powers as high as 1200 mW in each beam can be used, which lead to surface forces up 
to hundreds of pico-Newton without radiation damage to the cells. 
2.2.3.2. MOS setup  
The MOS setup used for our experiments has been design and built by the 
Softmatterphysics group of University of Leipzig (Germany). It consisted of two laser 
beams (λ= 1,064 nm) provided by two Ytterbium fiber lasers 5W YLM-5-1064 (IPG 
Photonics, Oxford, Massachusetts) with the laser guiding fibers aligned opposing one 
another. The fibers were align using a SU-8 (epoxy-based negative photoresist) 
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patterned structure and then positioned perpendicular to a square glass capillary flow 
channel, where cells flow. Soft clamps serve as a strain relief for the fibers and the 
capillary connectors. The setup is positioned onto the translatable microscope stage and 
connected to flow tubing. The trap is set inside the capillary where cells flow (see 
figure 2.14): the height is as low as possible without the divergent beams interfering 
with the channel floor. With fiber centered about 25 µm above the floor with a spot size 
(radius) of about 12 µm at the channel centre cells can be sequentially trapped without 
settling in the channel (Lincoln B., Schinkinger S. et al. 2007) 
 
 
Figure 2.14 Phase contrast image of the capillary channel. 
Fibers are align perpendicular to the capillary. A cell is flowing down the capillary. Scale bar is 20 µm. 
Illustration was taken and adapted from (Lincoln B., Schinkinger S. et al. 2007). 
Flow was controlled by channel custom made computer controlled pressure  driven 
pump system. The cell suspension is delivered via cryovial directly connected to the 
micro-fluidic system. Stage temperature was set up at 23oC during experiments. During 
the stretching, due to a laser heating of 26oC/W, the temperature was calculated to be in 
the range of 48,8oC-54,2oC during the 2 s of stretching. Cell deformation was recorded 
using video phase contrast microscopy on an inverted microscope (Axio.Observer Z1, 
Zeiss). These images, typically recorded at 30 frames/s  with a digital CCD camera 
(A202k, Basler), were converted to contour data using a custom-made edge detection 
program (implemented in MatLab).  
2.2.3.3 Sample preparation  
Cells were grown normally in small flasks with the appropriate cell medium and  
trypsinized as described in section 2.1 some minutes prior to experiments they. Cells 
were counted using a Burker cell counting chamber and typically prepared in a density 
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range of 20− 50×104 cells/ml in order to assure that the cells can be found as regularly 
as possible within the flow while maintaining a reasonable distance between each one. 
A total volume of about 1 ml was standard for an experiment during which cells were 
serially trapped at low powers and deformed at higher powers (0.7–1.2 W per beam). 
The flow was stopped during each trap and deformation cycle. 
2.2.3.4 Experimental Approach to measure cell deformability 
Each cell was trapped with a laser power of 100 mW by each beam and subsequently 
stretched for 2 s with an higher laser power ranging from 866mW to 1200mW. The 
temporal development of the major axis was tracked for each individual cell and the 
relative axial extension or strain of each cell as a function of time in units of percent 
deformation  γ(t) was calculated  
        (eq. 2.8) 
where a(t) is the length of the major axis of the stretched cell, which is aligned with the 
beam axis, and a0 is the lencth of major axis before stretching (average of the a values 
during the first  second of the trap phase). An example of stretched cell is shown in fig. 
2.15. In our analysis, we took in consideration the relative major axis extension as a cell 
classification parameter. 
 
 
Figure 2.15:  
Deformation of a cell in an optical stretcher. Cell deforms by 6.5 % along the laser axis, as determined 
by image analysis, when the light power is increased from 0.1 W (A) to 1.7 W (B) in both beams. Taken 
from Guck J. 2005. 
 
Due to the small focal depth of the imaging system, only a cross section of the cells was 
imaged. After each experiment images were analyzed separately and converted to 
contour data using a custom-made edge detection program (implemented in Matlab) 
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partially based on the  description in (Lincoln B., Schinkinger S. et al. 2007). Data have 
been analyzed in a phenomenological way and took in consideration only the optical 
deformability as a cell classification parameter (Lincoln et al. 2004; Guck et al. 2005). 
However depending on the application data could be potentially more rigorously 
modelled to obtain physical properties such as the frequency-dependant shear modulus 
of the cell (Wottawah et al. 2005). 
2.3 Western Blot Analysis 
2.3.1. Protein extraction 
Proteins were extracted from cells using a Lysis Buffer for native proteins containing 
50mM Tris-HCl pH 8.0, 0,4M NaCl, 1% NP40, proteases inhibitor 1X. The lysis buffer 
was freshly prepared prior to each extraction. Cell cultures were trypsinized as 
described in section 2.1 and cell pellets were washed 3 times with sterile PBS. Pellets 
were kept on ice and incubated for 4 minutes with cold lysis buffer, vortexed well for 1 
minute and placed on ice .This cycle was repeated for 5 times until suspension looked 
homogeneous. The volume of lysis buffer used depends on the cell pellet volume. The 
smaller the lysis buffer volume the highest the final protein concentration, however too 
small volumes prevent proper cell lysis: typical extractions from 2-3 x 10 6 cells 
required about 1 ml of Lysis Buffer.  
After vortexing, the samples were centrifuged for 10 mins at 5000g at 4oC and the 
supernatant containing the total protein extract was collected. During the protein 
extraction procedure the tubes containing cell pellets were kept on ice to avoid protein 
degradation.  
Proteins were quantified by Bradford assay (Biorad) as suggested by the manufacturer 
Some aliquots were immediately used, the others were stored at -80oC up to use. Prior 
to western blot analysis proteins were run in an SDS-PAGE to verify the success and 
the quality of protein extraction.  
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2.3.2.Western blot analysis 
Ten micrograms aliquots of cell lysates were separated on denaturing 12% 
polyacrylamide gels and electroblotted onto nitrocellulose membranes (Millipore) 
Afterwards membranes were blocked with 5% non-fat milk powder in PBS or TBS 
containing 0,05% Tween 20 for 1 hour at room temperature, then the primary antibody 
was added and the membranes were incubated separately again for 1-2hours. The 
choice of PBS or TBS, the antibody concentration and the time of incubation were 
related to the antibody type we were going to use: for each antibody we followed the 
manifacture’s protocol.  
 
Primary Antibodies 
Protein Host/Ab Type Diluition Manifacturer 
CK 18 Rabbit Ronoclonal 1:5000 Millipore 
CK8 Mouse Monoclonal 1:5000 Millipore 
Vimentin Goat Polyclonal 1:100 Millipore 
E-Cadherin Mouse purified antibody 1:5000 BD Bioscience Pharmigen
Integrin αVβ3 Mouse Monoclonal 1:1000 Millipore 
Vinculin Mouse Monoclonal 1:1000 Millipore 
 
Table 2.1:  
List of the primary antibodies used for immunoblotting experiments. Informations on antibody type, 
host, diluition, and manufacturer are reported 
 
After incubation with the primary antibodies membranes were washed with PBS or 
TBS containing 0,05% Tween 20 (SIGMA) - 5 washings of 5 minutes each - and then 
incubated with the proper secondary antibody. We used horseradish peroxidise (HRP)-
conjugated IgG (anti-mouse, anti-rabbit from DAKO or ImmunoPure Rabbit Anti-Goat 
IgG from Thermo Scientific dilution 1: 20000). After each antibody’s incubation, the 
membranes were washed with PBS or TBS containing 0,05% Tween 20. Signals were 
developed using the enhanced chemiluminescence system (Luminata Forte Western 
HRP substrate, Millipore). After each experiment membranes were incubated again 
with a HRP-conjugate Beta actin antibody as positive control. Densiometric signal 
intensities of the detected spots were calculated with Image J software. 
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2.4 Super resolution cytoskeleton imaging by fluorescence microscopy 
2.4.1 Cell staining preparation 
Immunofluorescence was performed on the three cell lines analyzed MDA-MB-231, 
MCF-7 and HBL-100 to investigate their cytoskeletal organization. 
To visualize the actin cytoskeleton structure  the following protocol was used: cells 
were grown on coverslips, fixed in 3% paraformaldehyde for 20 minutes at room 
temperature and then washed for 5 minutes with 0.1M NH4Cl in PBS. Permeabilization 
and blocking was performed by incubation in TritonX-100 0,1% in PBS+ 1% BSA for 
1 hour at room temperature. To label the actin cytoskeleton cells were incubated with 
Phalloidin (Phalloidin-atto 590, attotech) at a diluition of 1:100 1hour at room 
temperature and washed 3 times with PBS and once with water prior to mount the 
coverslip. 
2.4.2. Stimulated Emission Depletion (STED) super resolution imaging principle 
The images were recorded with a custom-built STED microscope of the group of Prof. 
Stefan Hell from the Department of NanoBiophotonics of Max Planck Institute for 
Biophysical Chemistry in Göttingen, Germany. The set up (Bückers J., Wildanger D. et 
al. 2011), combines two pairs of excitation and STED laser beams, all stemming from a 
single supercontinuum laser source (Wildanger D., Rittweger E. et al. 2008; Wildanger 
D., Medda R. et al. 2009). Whereas the excitation wavelengths (570±2 nm and 650±2 
nm) were selected from the supercontinuum using an acousto-optical tunable filter 
(AOTF, AA Opto-Electronic, Orsay Cedex, France) the STED wavelengths (720±10 
nm, 755±15 nm) were extracted using prism monochromators ensuring strict 
wavelength selections. After filtering the appropriate wavelength ranges, the four 
beams were coupled into separate polarization-maintaining single mode fibers. At the 
fiber outputs the beams were collimated and sent to the objective lens. The 
corresponding excitation and STED beams were combined using dichroic mirrors to 
give two pairs of beams with orthogonal polarization. The beam pairs were then 
combined with a polarizing beam splitter cube and coupled into the objective lens (PL 
APO 100×/1.40–0.7 oil, Leica Microsystems, Wetzlar, Germany). Two vortex phase 
plates (RPC Photonics, Rochester, NY, USA.) placed into the STED beams followed 
by a superachromatic quarterwave plate (600–2700 nm, B. Halle GmbH, Berlin, 
Germany) placed at the back of the objective lens afforded ring-shaped STED foci with 
a zero-intensity minimum in their center.  
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To ensure spatial overlap of the excitation and the STED foci, the diffraction patterns 
(„point spread functions PSFs”) of the four beams were measured sequentially by 
recording scattered light from gold nanoparticles (80 nm) as they were scanned through 
the focal region. The alignment precision was on the order of 5 nm, i.e. below the 
resolution achievable with the setup.  
Since all four laser beams originated from a single source, no pulse synchronization 
was necessary. Still, the simultaneous arrival of the excitation and the respective STED 
beam in the sample had to be adjusted by matching the optical path lengths for each 
pair of beams. On the contrary, the pairs of excitation and STED beams for the two 
colour channels were time-shifted by about 40 ns using optical fibers of different 
lengths. This pulse-interleaved acquisition scheme enabled the (quasi-)simultaneous 
recording of both colour channels: in addition to the spectral separation photons were 
assigned to a dye according to their arrival time at the detector. Due to the simultaneous 
recording of both colour channels hardly any shift of the sample was possible during 
the recording time.  
The fluorescence from the two fluorophores was separated from the laser beams with a 
custom made multiband dichroic mirror (Chroma Technology, Rockingham, VT, 
USA). It was subsequently split up with a second dichroic mirror (Z635RDC, Chroma 
Technology) according to the maximum emission of the different dyes, and was finally 
cleaned up with bandpass and longpass filters (M620/40, M670/40 nm and Z660LP, all 
from Chroma Technology). The fluorescence was then focused into separate multimode 
optical fibers (Ø = 62.5 μm, Thorlabs, Dachau, Germany) which served as confocal 
pinholes. The fibers were attached to single-photon counting modules (SPC-AQRH-13-
FC, Perkin Elmer, Salem, MA) which were connected to custom time gating electronics 
extracting the fluorescence signals following each of the excitation/STED pulse pairs. 
Optionally, for the acquisition of fluorescence lifetime data, the time trace of the 
fluorescent signals was measured by a time-correlated single-photon counting (TCSPC) 
module (SPC-730, Becker & Hickl GmbH, Berlin, Germany).  
52
 
 
 
 
Figure 2.16 
Setup of the multi-lifetime/multi-color STED microscope. (Bückers J., Wildanger D. et al. 2011) 
2.5 MALDI-MS 
We used matrix-assisted laser desorption and ionization (MALDI) mass spectrometry 
(MS) to characterize the lipid composition of cells. We performed semi-quantitative 
analysis to compare the lipid composition of the three different cell types and find out 
significative differences among them. MALDI-MS is a well established technique in 
the study of proteins but there is increasing evidence that MALDI MS is also very 
useful in lipid research, because it is fast, sensitive, it tolerates sample impurities to a 
relatively high extent and it provides very simple mass spectra without major 
fragmentation of the analyte (Fuchs B., Süß R et al. 2010). 
2.5.1. MALDI-MS technique principles 
The technique of mass spectrometry determines the elemental compositions and/or 
molecular structures of compounds by measuring the mass-to-charge (m/z) ratios of 
generated ions. Traditional “hard” ionization techniques have been used in lipid 
chemistry in early days, but the development of modern “soft” ionization methods 
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significantly facilitated the analysis of lipids and phospholipids. One of these is the 
MALDI technique that will be described in this section. 
As indicated by its name, a typical MALDI-MS is based on a matrix that absorbs laser 
energy (Schiller J., Süss R. et al. 2006). IR and UV lasers that are normally used on 
commercially available MALDI devices. The use of matrix is essential in the design of 
MALDI in that it absorbs the laser energy, and prevents aggregation of the analytes. In 
most cases, an organic matrix solution is mixed with the analyte solution and 
afterwards crystallized on a metal "target" plate.  
 
 
Figure 2.17 
Schema of the processes occurring during the MALDI-TOF ionization process in the mass spectrometer). 
The influence of the detection using the ‘‘linear” and ‘‘reflector” mode is emphasized in the figure. 
Adapted from (Baldwin MA. 2005) 
As shown in Figure 2.17, when the laser beam hits the sample, the matrix (which is in a 
large excess over the analytes) primarily absorbs the laser energy and evaporate 
together with the analytes. Singly charged molecular ions of the analytes are formed in 
this evaporated gas phase, when H+ and other possible ions such as Na+ are exchanged 
between matrix and analytes. Although multiply charged molecules can also be 
generated, they are more easily neutralized and less stable. This is the well-known 
"lucky survivor" model (Karas M., Glückmann M. et al. 2000)., Although not 
mandatory (MALDI can be also combined with a quadrupole, ion trap or Fourier 
transform ion cyclotron resonance (FTICR) analyzer), the most commonly used mass 
analyzer combined with a MALDI ion source is the time-of-flight (TOF). Formed 
molecular ions are accelerated in a strong electric field (normally about 20,000 V) and 
enter a field-free space through a charged grid with the same energy. Invertion of the 
direction of the electric field leads to the differentiation of positive and negative ions. 
In this space they fly in a speed according to their mass: light ions travel faster and 
arrive at the detector earlier than heavier ions. Using a "reflectron" that enhances the 
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flight path and is useful to compensate for differences in the initial velocities of the 
generated ions, mass resolutions of about 20000 and mass accuracies of the order of 20 
ppm can be obtained (Hillenkamp F. and Peter-Katalinic J. 2007). As stated above, the 
matrix in a MALDI-MS is of great importance. A “good” matrix should have 
reasonable absorption properties at the laser wavelength (often 337 nm), good mixing 
properties with the analyte for homogeneous co-crystallization, reasonable high-
vacuum stability and low yield of matrix ions that are generated by photochemical 
reactions such as "cluster" ion formation (Hillenkamp F. and Peter-Katalinic J. 2007). 
The last requirement is especially essential for lipid analysis, since typical lipid 
molecules generate ions with rather low mass.  
2.5.2 MALDI setup description 
For our experiments MALDI mass spectra were acquired on a Bruker Autoflex mass 
spectrometer. The system utilizes a pulsed nitrogen laser, emitting at 337 nm. The 
extraction voltage was 20 kV and gated matrix suppression was applied to prevent the 
saturation of the detector by matrix ions (Schiller J., Suss R. et al. 2007). 128 single 
laser shots were averaged for each mass spectrum. The laser strength was kept about 
ten percent above threshold to obtain optimum signal to noise ratio. In order to enhance 
the spectral resolution all spectra were acquired in the reflector mode using delayed 
extraction conditions. 
2.5.3. Lipid extraction and sample preparation 
In order to analyze the  composition of cells, lipids were purified from cell pellets to 
remove salts and polar compounds such as proteins or carbohydrates. 
More precisely, cells were trypsinized to detach them from flasks surface and 
centrifuged as described in section 2.1 and cell pellets were washed 3 times with sterile 
PBS to remove any medium or trypsin solution residues. Cell pellet was resuspended in 
PBS and cells were counted with a Bruker counting chamber. Cells suspension was 
diluited  2 millions of cells each. This procedure was performed for each of three cell 
lines (MDA-MB-231, MCF-7 and HBL-100). : Since  lipid evaluation through 
MALDI-MS is a semi-quantitative analysis, it was crucial to analyse the same amount 
for  each cell type.. Lipid extraction can be made directly after cells preparation: for 
practical reason in our case we kept cell pellets at -80oC in falcon tubes for a couple of 
days prior lipid extraction. A well established extraction method was introduced by 
Bligh and Dyer (Bligh E.G. and Dyer W.J. 1959). For each cell pellet, 3,75 ml of 1:2 
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(v/v) CHCl3:MeOH were added followed by  . 1,25 ml CHCl3  and  finally 1,25 ml 
dH2O. After each solvent addition, the  sample  was  vortexed for a long time. Then the 
sample was centrifuged at 1000 RPM in IEC table-top centrifuge for 5 min at room 
temperature to obtain a two-phase system: the aqueous phase remained on the top while 
the  organic one at the bottom. Due to the solubility of lipids in apolar organic solvent, 
lipids are easily extracted into the organic (chloroform) layer. Impurities (such as 
inorganic salts) are readily purified from the lipid extracts, since they remain in the 
aqueous layer. The organic phase was recovered with a Pasteur pipette through the 
upper phase with gentle positive-pressure taking care that the upper phase could not get 
into the pipette tip. Although the use of chloroform is nowadays strongly discouraged 
because it represents a harmful solvent, the vast majority of work in the lipid field is 
still based on the use of chloroform. Although a lot of different extraction methods, for 
instance hexane and isopropanol or methyl-tert-butyl ether have been introduced, these 
techniques are not widely accepted so far. 
Afterwards two aliquotes of each lipid mixture were separately mixed with two 
different matrices : 2,5-Dihydroxybenzoic acid (DHBfrom Fluka Chemie GmbH, 
Buchs, Switzerland)  and 9-Aminoacridine( 9-AA from Sigma-Aldrich Chemie GmbH, 
Steinheim, GermanyDHB). The mixture was added to  the target, dryed and analyzed. 
The remaining lipid samples was storaged at -20oC. 
Since lipids and common matrices such as DHB and 9-AA are generally soluble in the 
same organic solvents, they are usually mixed together and applied on the target, where 
the solvent evaporates and matrix, typically in a 100-1000-fold molar excess, co-
crystallizes with the analytes.  
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3. EXPERIMENTAL RESULTS 
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3.1 Biomechanical properties measurements 
3.1.1 OT viscoelasticity measurements results 
3.1.1.1 Custom built OT setup 
The OT set up used in this work has been designed and built in the Optical 
Manipulation lab of CNR-IOM (Istituto Officina Materiali). The components and setup 
configuration are described in section 2.2.1.2. 
The set up has been used to measure the local viscoelastic properties of human cell 
lines MDA-MB-231, MCF-7 and HBL-100 by membrane tether pulling experiments. 
The experimental approach is described in section 2.2.1.4. 
3.1.1.2. Experimental data analysis: Force Elongation (FE) curve and its 
interpretation 
Experimental data obtained by a single tether pulling experiments are plotted to derive 
a FE curve from which we can extract the local viscoelastic properties of the cell as 
described in section 2.2.1.4. A typical FE curve is shown in figure 2.10.  
FE curve is consistent with the assumption that the force necessary to pull a tether from 
membrane must overcome the membrane bending rigidity, the membrane tension, the 
adhesion of the phospholipid membrane bilayer to the cytoskeleton and the viscous 
resistance of the phospholipid bilayer (Sheetz 1996, Raucher 1999, Sheetz 2001). The 
shape of our FE curve is similar to those previously reported in literature for cancer 
neuronal cells (Guo 2004) and other types of cells (Hochmuth 1996, Li 2002, Ermilov 
2005). 
The FE curve (see figure 2.10 in 2.2.1.4) has typically three regions: 
(1) the elastic region, where the elastic regime dominates in the first part until the 
membrane separates from the cytoskeleton. In a first approximation, by linear fitting of 
this region of the curve, elasticity could be expressed by a single parameter, the tether 
stiffness kT. 
(2) the point of maximum force (FT), where the membrane is supposed to detach from 
the cytoskeleton. This part is followed by a rapid dropping of the force; 
(3) the viscous regime (VT),  indicated by a force value which remains constant until 
the depletion of the membrane reservoir allows tether elongation. 
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3.1.1.3. Analysis of the temperature dependence of the cell membrane visoelastic 
properties. 
In order to investigate the cell membrane viscoelastic properties dependence with the 
temperature we have performed tether pulling experiments at two different 
temperatures: room temperature (25oC) and physiological temperature (37oC), for one 
of the cell types. 
Experiments were performed with the metodology described in 2.2.1.4. We calculated 
the trap stiffness by acquiring the Brownian motion of the trapped bead for 2 seconds at 
2 kfps, prior to each experiment. The laser power arriving at the sample was 5% from 
the laser power at the source: using a laser power of 800 mW we have obtained a trap 
stiffness kOT = 0.21 pN/nm in both X and Y directions. 
During the tether formation, the image acquisition rate was reduced to 100 fps, keeping 
instead a larger frame, which allows to image also the cell. 
In order to extract the viscoelastic feature of the cell from the FE curve we have 
calculated the following three parameters: tether stiffness( kT), tether force (FT), tether 
length (LT) at FT and tether viscosity( VT). The kT is given by the slope of the linear fit 
of the curve in the elastic regime with least squares method. The FT is represented by 
the maximum force reached at the end of the elastic regime, when the membrane 
detaches locally from the cytoskeleton. Finally, the VT is given by the ratio between the 
median value of the force in the third region and the velocity at which the stage is 
moved.  
We have first measured a series of tethers formed from ten MDA-MB-231 cells at room 
temperature (25 ºC). Then, we repeated the same measurements for other ten cells, 
keeping the sample cell at the physiological temperature (37 ºC). 
 
 
Table 3.1 
Mean values and standard deviations of the viscoelastic parameters measured for two series of ten 
MDAMB- 231 cells at room and physiological temperatures respectively. 
The results, presented in Table 3.1, show a significant difference of the cell behaviour 
when the temperature is changed. At room temperature the tether membrane is less stiff 
than at physiological temperature, while the viscosity is higher. Expectedly, the tether 
force is higher, while the tether length is shorter for physiological conditions.  
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These results demonstrate that the temperature variation, even for short period (10-20 
min) change significantly their viscoelastic properties, even if the morphology is not 
modified. 
This conclusion has to be considered when measurements on different types of cells are 
performed, because the experimental conditions must be strictly identical. 
3.1.1.4.Viscoelastic parameter extraction from FE curves using the Kelvin model 
A linear fitting of the three regions of the FE curve could represents a first 
approximation for the elasticity, allowing the estimation of the tether stiffness and the 
viscosity. To get more information about the tether formation mechanism, we have 
analyzed in detail the FE curves and fitted them using a more complex model including 
two elastic components and a viscous element. Figure 2.9 shows that the FE curve is 
increasing monotonically but is not linear. Since the FE curve of pulling tether has the 
characteristics of viscoelastic solids (Li Z. 2002), it makes sense trying to use similar 
models to interpret it. One well-established model for viscoelastic solids is the Kelvin 
body, which has been also proposed to describe the viscoelastic properties of cells 
investigated by magnetic bead microrheometry (Bausch A. R. 1998) or tether pulling 
with AFM (Schmitz J., Benoit M. et al. 2008). Observing the shape of the FE curve we 
assume that the cell behaves like a Kelvin body also under tether pulling experiments 
with OT. The Kelvin mechanical model is represented in figure 3.1.The cell is thus 
described by three parameters: the spring constant, kT, representing the tether stiffness, 
the spring constant, kBe, representing the bending rigidity and the tension of the 
membrane and a dashpot with viscosity, VT, representing the viscosity of the cell 
membrane (Sheetz M.P. and 2001). 
 
 
Figure 3.1: Kelvin body mechanical model adopted for cells. The Kelvin body consists of a spring 
with spring constant kT representing the tether stiffness, and parallel to this spring a series of a second 
spring with spring constant kBe representing the bending rigidity of the membrane and a dashpot with 
viscosity VT. 
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Transforming the differential equation for the Kelvin body into a time dependency of 
the force, under the boundary condition of a constant retraction velocity, and null force 
at the moment zero, one gets the following force-elongation equation (Schmitz 2008): 
  (eq.3.1) 
where x is the elongation and v the extension velocity. Using this analytical 
relationship we have fitted the FE curves. The fit was made dividing the FE curve into 
different intervals: in each one the values of the Kelvin Body parameters have been 
changed as soon as the fitted curve differed too much from the experimental values. For 
each FE curve we calculated the mean values of the three parameters. 
The membrane bending rigidity is related to the local deformation of the cell and 
expressed by the spring constant kBe: it is dominant at the beginning of the pulling 
decrease when the membrane tether almost detaches from the cytoskeleton, becoming 
insignificant when the tether membrane is detached. Tether stiffness, expressed by the 
spring constant kT, is related to the adhesion points between the inter-membrane 
proteins and the cytoskeleton has a different behaviour. It increases to a maximum 
value before the rupture process begins. The tether stiffness is then reduced. The 
bending rigidity and membrane tension components are insignificant after the 
maximum force FT is reached . This is consistent with the fact that the cell membrane is 
no more tensed. Analysing the viscosity values VT for the different sub-regions one can 
see that there is a major contribution in the region after the rupture point, where the 
viscous flow is evident. Nevertheless, there are contributions also at the beginning of 
the pulling process, showing that a viscous regime, even if it is weak, should be 
coupled to the elastic regime. In conclusion, the interpretation of the FE curve with the 
Kelvin body model could provide additional information related to the mechanism of 
tether formation. 
3.1.1.5.Comparative analysis of the local viscoelastic parameters extracted for the 
breast cell lines 
Cells for tether pulling experiment were randomly selected as long as they had a 
healthy morphology. We pulled tethers in random positions between the top of the cell 
and the final edge. No tether was pulled a second time since it was reasonable that 
tether structure changes definitely in response to the first pulling. In some cases we 
repeated more than one measurement on the same cell, at different position, at least 5 
micron far one to each other. Each experiment was performed at 37oC, tethers of 
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several µm were pulled out with a velocity of 0.5 µm/sec. Experiments in which 
floating beads or cellular debris interfered with the bead during the tether pulling were 
invalidated and not considered. 
Membrane tether pulling experiments on cell lines with different level of 
aggressiveness were performed on sample sizes of 8-10 cells. To reduce variability as 
much as possible we incubated cells in the presence of Ara-C for 18 hours prior to the 
experiment in order to synchronize cell cycle.  
Using MATLAB we fitted experimental data with Kelvin body model to extract the 
three parameters: tether stiffness (KT), membrane bending rigidity (Kbe) and viscosity 
(VT). We analyzed the parameters using the Data Analysis and Statistical Software 
STATA SE9.2. 
Values of the elastic and viscous parameters extracted from the OT experiments are 
reported in Figures 3.2, 3.3 and 3.4 
 
Tether Stiffness (KT) 
 
Tether Stiffness MDA-MB-231 MCF-7 HBL-100 
Median 18,1 pN/µm 32,5 pN/µm 75,0 pN/µm 
Mean 20,7±11,6 pN/µm48,04±41,3  pN/µm76,7±42,9 pN/µm 
 
Figure 3.2: Box plots representing the Tether Stiffness values of MDA-MB-231, MCF-7 and HBL-
100 cell lines. 
(a) Box plot representing the Tether Stiffness values (in pN/µm) of the three cell lines. Values were 
obtained with OT tether pulling experiments. The blue boxes contain values from the 25o percentile to 
the 75o percentile. Horizontal lines in the blue boxes represent the median value. (b) Table indicating the 
median and the mean values of Tether stiffness of the three cell lines. Significant p value has been 
reported above box plots.  
The tethers stiffness mean value for the higher aggressive neoplastic cells, MDA-MB-
231 (20,7 pN/µm) is 3,7 times lower than the tether stiffness mean value (76,7 pN/µm). 
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of HBL-100, the immortalized cell line. Despite the high standard deviations, 
significant differences were detected by ANOVA test between the two cell types MDA-
MB-231 and HBL-100 (p=0,02). 
MCF-7 cell type exhibits a tether stiffness value (48,04 pN/µm ) which is in between 
the two groups of MDA-MB-231 and HBL-100. No significant differences were 
detected for this type of cell.  
 
Membrane Bending Rigidity (Kbe) 
 
 
 
Membrane Bending Rigidity MDA-MB-231 MCF-7 HBL-100 
Median 80,8 pN/µm 77,5 pN/µm 125,0 pN/µm 
Mean 71,2±34,7pN/µm79,3±49,3pN/µm 175,4±104,2pN/µm
 
Figure 3.3: Box plots representing the Membrane Bending Rigidity values of MDA-MB-231, MCF-
7 and HBL-100 cell lines. 
(a) Box plot representing the Membrane Bending rigidity values (in pN/µm) of the cell lines. Values 
were obtained by OT tether pulling experiments. The boxes contain values from the 25o percentile to the 
75o percentile. Horizontal lines in the blue boxes represent the median value. (b) Table indicating the 
median and the mean values of Membrane Bending Rigidity of the three cell lines. Significant, p value 
are reported above box plots. 
The membrane bending rigidity of the breast cancer cell types MDA-MD-231 and 
MCF-7 showed lower values compared to the non-neoplastic (but immortalized) cells 
HBL-100. 
In particular the membrane bending rigidity mean value of MDA-MB-231 (71,2 pN/µm 
) is 2,5 times lower that the one of HBL-100 (175,4 pN/µm). The ANOVA test 
confirmed that these values are significantly different with p=0,02. 
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The membrane bending rigidity mean value of MCF-7 (79,3 pN/µm) is 2,2 times lower 
that the one of HBL-100 (175,4 pN/µm). Again ANOVA test confirmed that these 
values are significantly different with p=0,004. 
Membrane bending rigidity mean values of the two breast cancer cell types MDA-MB-
231 and MCF-7 were comparable and no significant differences were detected between 
them. 
 
Viscosity (VT) 
 
 
ViscosityMDA-MB-231 MCF-7 HBL-100 
Median 33,9 pN*s/µm 15,0 pN*s/µm 7,5 pN*s/µm 
Mean 59,7 pN*s/µm 25,5  pN*s/µm25,5 pN*s/µm 
 
Figure 3.4: Box plots representing the Viscosity values of MDA-MB-231, MCF-7 and HBL-100 cell 
lines. 
(a) Box plot representing the Viscosity values (in pN*sec/µm) of the three cell lines. Values were 
obtained by OT tether pulling experiments. The blue boxes contain values from the 25o percentile to the 
75o percentile. Horizontal lines in the blue boxes represent the median value. (b) Table indicating the 
median and the mean values of Viscosity of the three cell lines. The value of p is reported above the box 
plots.  
 
The viscosity values showed an inverse tendency with respect to the elastic parameters: 
the metastatic cells exhibit higher viscosity values if compared to the non-neoplastic 
cells. 
HBL-100 showed a mean viscosity value (10,5 pN*s/µm) six times lower than MDA-
MB-231 (59,7 pN*s/µm ) and 2,5 lower than MCF-7 (25,5 pN*s/µm). 
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The difference between MDA-MB-231 and HBL-100 was not significant, but  
borderline (p=0.07).  
To conclude, elastic parameters such as Tether Stiffness and Membrane Bending were 
higher in those cells associated to malignancy and high aggressive behaviour. On the 
contrary, viscosity showed an inverse tendency increasing with the progression of the 
malignancy and the aggressive behaviour of the tumour cell. We observed very high 
standard deviations suggesting that cell lines were very heterogeneous in terms of 
biomechanical properties and more experiments should be done to have significant 
statistical data and confirm our observations. 
3.1.2 Elastic modulus by AFM 
3.1.2.1.Comparative analysis of the parameters extracted for the three cell lines 
Before AFM experiments, cells were cultured in the same conditions as described in 
section 2.1.2. Cells were plated on a glass coverslip at low density to have  isolated and 
not overlapping cells, in order to facilitate the choice of the cell and clearly distinguish 
its morphology before the measurement. We selected cells randomly as long as they 
looked healthy and they had the typical morphology of their cell line. Probes were 
positioned under optical control in the region between nucleus and the edge of the cell, 
a constant approach velocity of 5μm/s during the extend and 10 μm/s during the extend 
was used. 
Velocity during the extend was maintained consistent in each experiment: this is a 
crucial point because differences in indentation velocity brings variations in force 
indentation measurements. Higher velocities results in higher resistance of the sample 
material and over all interaction is more viscous. Thus, the higher is the loading rate, 
the smaller is the indentation at a given force and the higher is the apparent stiffness. 
Non consistent velocities in experiments would have invalidate the measurements. 
Indentations were performed with a cantilever functionalized with a silica bead to avoid 
cell membrane damages caused by the sharp cantilever tip; the indentation depth was 
500nm, which is 5-10% that the extimated cell thickness 
To obtain a statistically significant Young’s Modulus on each cell, we performed 25 
measurements in different positions, distributed in a grid of 5µm x5µm on the cell 
surface. We analyzed 10 cells for each cell type (MDA-MB-231, MCF-7 and HBL-
100) resulting in 250 measurements for each cell line.  
Experiments were performed at room temperature (25oC) with no CO2 concentration 
control: to avoid temperature or pH acidification damages as much as possible we 
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changed sample every 30 minutes. To calculate the apparent cell elasticity the JPK 
software applied the Hertz model by automatic fitting and derived the Young’s 
Modulus (E).   
We used ANOVA test to see if there were significative differences between each cell 
line. Young’s Modulus values are reported in figure 3.5: 
 
Young’s Modulus (E) 
 
 
Young’s ModulusMDA-MB-231 MCF-7 HBL-100 
Median 87,5 kPa 120,4 kPa 63,1 kPa 
Mean 95,1±57,7 kPa 134,0±147,8137,0±147,8 kPa
 
Figure 3.5: Box plots representing the Young’s Modulus values of MDA-MB-231, MCF-7 and 
HBL-100 cell lines. 
(a) Box plot representing the Viscosity values (in pN*sec/µm) of  the three cell lines. Values were 
obtained by AFM indentation experiments. The blue boxes contain values from the 25o percentile to the 
75o percentile. Horizontal lines in the blue boxes represent the median value. (b) Table indicating the 
median and the mean values of Viscosity of the three cell lines. Where ANOVA test showed 
significativity, p value has been reported above box plots. 
 
Looking at the median Young’s Modulus values we may conclude that higher Youngs 
Modulus values and higher resistance to deformation are associated with breast cancer 
cells MDA-MB-231 and MCF-7 compared to the immortalized HBL-100 cell line. 
Nevertheless mean values are not coherent. Young’s Modulus values were quite spread, 
we observed very high standard deviations suggesting that cell lines were very 
heterogeneous in terms of biomechanical properties. Despite ANOVA test showed that 
differences were significative a net discrimination in terms of elasticity is difficult. 
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3.1.3 Cell deformability measurements by MOS 
We tried to analyze the three cell types by the measurement of their time-dependent 
response to a stress using MOS. 
The cell types MDA-MB-231, MCF-7 and HBL-100 were analyzed each in separate 
measurement series. Cells were prepared as previously described in section 2.2.3.2 and 
connected to the microfluidic system: subsequently each cell was trapped with a laser 
power of 100 mW  from each beam, and deformed for 2 s with a laser power of 866 
mW, 1033 mW or 1200 mW from each beam. The laser power was chosen randomly 
by an alghoritm. As described in section 2.2.3.4 the evaluated parameter was the 
relative axial extension γ(t)  of each cell as a function of time in units of percent 
deformation, 
In figure 3.6 the plot of the average relative axial deformation of each cell type in 
response to the stretching by different laser powers. Cell deformation is proportional to 
the force applied on the cell 
 
 
Figure 3.6.  
Plots of the average relative axial deformation of (a) MDA-MB-231(b) MCF-7 (c) HBL-100 as a 
function of time for different laser powers: 1200 mW (violet curve), 1033 mW (yellow curve) and 866 
mW (blu curve)  
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Since cell response to stress is different in relation to the entity of the stretching we 
analyzed and compared the relative axial deformation of the three cell types at three 
different laser powers: 866mW, 1033 mW and 1200mW 
The average relative axial extension for each cell type can be used to show the different 
average response from the three populations. 
 
 
Figure 3.7. 
Plots of the relative axial deformation as a function of time of (a) 71 individual MDA-MB-231 cells (b) 
131 individual MCF-7 cells and (c) 141 individual HBL-100 cells trapped at 100 mW and stretched for 2 
s  at laser power of 866 mW. Finally (d) plot of the average relative axial deformation of MDA-MB-231 
(red curve), MCF-7 (violet curve) and HBL-100 (blue curve) cells. 
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Figure 3.8: 
Plots of the relative axial deformation as a function of time of (a) 40 individual MDA-MB-231 cells (b) 
161 individual MCF-7 cells and (c) 141 individual HBL-100 cells trapped at 100mW and stretched for 2 
s at laser power of 1033 mW. Finally (d) plot of the average relative axial deformation of MDA-MB-231 
(red curve), MCF-7 (violet curve) and HBL-100 (blue curve) cells. 
 
 
Figure 3.9 
Plots of the relative axial deformation as a function of time of (a) 24 individual MDA-MB-231 cells (b) 
118 individual MCF-7 cells and (c) 67 individual HBL-100 cells trapped at 100 mW and stretched for 2 s 
at laser power of 1200 mW. Finally (d) plot of the average relative axial deformation of MDA-MB-231 
(red curve), MCF-7 (violet curve) and HBL-100 (blue curve) 
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In both the stretching experiments using 866 mW and 1033 mW as laser power, MCF-7 
cells exhibit more resistance to deformability compared with MDA-MB-231. If higher 
stretching force (1200 mW) is used, MDA-MB-231 and MCF-7 resistance to 
deformability is comparable. 
HBL-100 showed to be more deformable than the other two cell types for the different 
stretching force. 
3.2 Proteomic analysis results by Western Blotting 
We performed immunoblot analysis on the whole protein extracts of the three cell 
types: MDA-MB-231, MCF-7 and HBL-100. Protein extraction and western blot 
analysis procedures are described in 2.3. In order compare the expression patterns of 
the three cell types we performed semi-quantitative analysis by loading on SDS-PAGE 
the same amount of proteins (10 mg). Each Western Blot analysis was repeated three 
times in the same experimental conditions to verify results’ repeatability. We tested the 
expression patterns of 6 proteins: 
1. E-cadherin, which is involved in the cell-cell adhesion. Its down-regulation is related 
to epithelial mesechymal transition and neoplastic transformation Heimann R., Lan F.S. 
et al. 2000 Siitonen S.M., Kononen J.T. et al. 1996).  
2. Cytokeratins 8/18, which is a marker for the discrimination between luminal and 
basal tumours of the beast (Delgallo W.D., Rodriguez J.R.P. et al. 2009) 
3. Vimentin.  Intermediate filaments are involved in cell transformation and malignant 
progression (Gilles C., Polette M. et al. 2003; Korsching E., Packeisen J. et al. 2005) 
4. Integrin αvβ3 and Vinculin, which are involved in the Cell-Extracellular Matrix 
(ECM) interactions and thus are related to cell adhesion and cell migration.  
Since MDA-MB-231 and MCF-7 are widely used and well-characterized cell models, 
their E-Cadherine, CK8/18 and Vimentin expression patterns are well known. The aim 
of these analyses was to verify the expression patterns of the same markers in HBL-100 
and obtain information on its status. On the other hand, the expression patterns of 
Integrin αvβ3 and Vinculin could be useful to further characterize the malignancy 
status of the three cell types. HBL-100 is an immortalized cell line derived from milk of 
an apparently healthy woman. This cell line has been widely used as low 
aggressiveness model or ‘healthy’ control, however no clear data are available on the 
molecular classification of this cell line. In the present study we search the 
abovementioned markers in this cell type in order to provide a molecular classification 
for the comparison with biomechanical data. 
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3.2.1 Analysed molecular markers 
E-Cadherin 
E-cadherin is a trans-membrane glycoprotein, which interacts with several proteins 
collectively termed Catenins, that bind the actin cytoskeleton. E-cadherin mediates 
cell–cell adhesion and cell–extracellular matrix adhesion (Berx G. and Van Roy F. 
2001). Lost of E-cadherin protein is a hallmark of Epithelial Mesenchymal Transition 
(EMT), which is typical of embryonic development and cancer progression (Thiery J.P. 
2002; Thiery J.P. 2003).   
 
 
Figure 3.10: Protein expression pattern of E-cadherin 
Protein expression patterns of E-Cadherin (135 kda)in the three breast cell lines MDA-MB-231 MCF-7 
and HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS 
PAGE and stained by immunoblotting with primary and secondary antibodies. Β-actin (42 kDa) was 
used as control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the 
detected protein Vs the densiometric signal intensity of actin. ND, not detected. 
The immunoblot revealed positivity only for MCF-7 cell line, while MDA-MB-231 and 
HBL-100 resulted negative. This data was confirmed even in the replica of our 
experiments.  
 
CK 8/18 
Cytokeratins are proteins involved in the typical intermediate filaments, which 
characterize the epithelial cells’ cytoskeleton. In particular Cytokeratin 18 (CK18) 
together with its partner Cytokeratin 8 (CK8) are the most common products of the 
intermediate filament gene family (Omary M.B. et al. 1992).  
They are usually used as molecular markers to distinguish Luminal carcinomas from 
Basal –like carcinomas. Luminal carcinomas strongly express luminal cytokeratins 
(CK8 ⁄ 18). Basal-like carcinomas exhibit weak or focal positivity for CK8 ⁄ 18 
(Delgallo W.D., Rodriguez J.R.P. et al. 2009) 
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Figure 3.11: Protein expression pattern of CK18 
Protein expression patterns of CK18 (48kDa) in the three breast cell lines MDA-MB-231 MCF-7 and 
HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS PAGE 
and stained by immunoblotting with primary and secondary antibodies. Β-actin (42 kDa) was used as 
control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the detected 
protein Vs the densiometric signal intensity of actin. ND, not detected 
 
 
Figure 3.12: Protein expression pattern of CK8 
Protein expression patterns of CK8 (55kDa) in the three breast cell lines MDA-MB-231 MCF-7 and 
HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS PAGE 
and stained by immunoblotting with primary and secondary antibodies. Β-actin (42 kDa) was used as 
control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the detected 
protein Vs the densiometric signal intensity of actin. ND, not detected 
Cytokeratins 18 and 8 resulted positive in all the analysed cell lines, with a higher 
expression level for MCF-7 cells in comparison to MDA-MB-231 and HBL-100. Since 
cytokeratins are usually found in pairs comprising a type I (basic) cytokeratin and a 
type II (acidic) cytokeratin, the similar amount of CK8 and CK18 detected in this 
experiment is in agreement with their structure.  
 
Vimentin 
Vimentin is a intermediate filament (IF) protein, which forms part of the cytoskeleton 
and it is typically expressed in mesenchymal cells: its expression in epithelial cells is a 
hallmark of EMT. Expression of vimentin has been described in breast carcinomas 
(Azumi N. and Battifora H. 1987; Kokkinos M.I., Wafai R. et al. 2007) and aggressive 
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breast cancer cell lines (Gilles C., Polette M. et al. 2003). Higher vimentin expression 
level correlates well with up-regulated migration and invasion of cancer cells (Gilles 
C., Polette M. et al. 2003; Korsching E., Packeisen J. et al. 2005). The transfection of 
the non-invasive human breast cancer cell line (MCF7) with vimentin gene led to 
accelerated invasiveness (Hendrix M.J., Seftor E.A. et al. 1997).  
. 
 
Figure 3.13: Protein expression pattern of Vimentin 
Protein expression patterns of Vimentin (57kDa) in the three breast cell lines MDA-MB-231 MCF-7 and 
HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS PAGE 
and stained by immunoblotting with primary and secondary antibodies. Β-actin (42 kDa)was used as 
control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the detected 
protein Vs the densiometric signal intensity of actin. ND. Not detected 
Our experiments revealed positivity to Vimentin in MDA-MB-cells and HBL-100. On 
the contrary MCF-7 cells were negative for Vimentin. The expression level of 
Vimentin in MDA-MB-231 was higher than in HBL-100 cells (ratio 1,2 vs 0,9, 
respectively). 
 
Integrin αvβ3 
The integrins constitute a family of trans-membrane receptor proteins composed of 
heterodimeric complexes of non-covalently linked α and β chains. They are linked to 
the actin cytoskeleton involving talin, vinculin, and α-actinin as intermediaries. 
Integrins function in cell-cell and cell-extracellular matrix (ECM) adhesive interactions 
and transduce signals from the ECM to the cell interior and vice versa. Integrins 
mediate the ECM influence on cell growth and differentiation, and are involved in cell 
migration, cell invasion, cell intra- and extra-vasation. 
Integrins have been found on virtually every cell and tissue studied. During 
development, integrins are ubiquitously expressed. They regulate morphogenetic cell 
movements and migration; and are especially numerous during gastrulation, 
neurulation, and histogenesis (Albelda S.M. and Buck C.A. 1990). Integrin expression 
levels tend to decrease gradually during differentiation as adult structures emerge.  
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Expression of integrin αvβ3 is associated with progression of a variety of human 
tumours and it is expressed in some of the most aggressive tumour cells in a variety of 
cancers including also breast cancers (Mizejewski G.J. 1999). 
 
Figure 3.14 Protein expression pattern of Integrin αvβ3  
Protein expression patterns of αvβ3 integrin (130kDa) in the three breast cell lines MDA-MB-231 MCF-7 
and HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS 
PAGE and stained by immunoblotting with primary and secondary antibodies. Β-actin (42kDa) was used 
as control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the 
detected protein Vs the densiometric signal intensity of actin. ND, not detected 
 
 
Integrin αvβ3  were highly expressed in MDA-MB-231 and HBL-100 cells, in MCF-7 
the protein was detectable, but at lower expression level. The intensity of Integrin in 
MDA-MB-231 and HBL-100 was similar as reported in Fig 3.14.  
 
Vinculin 
Vinculin is a cytoplasmic actin-binding protein and represent the major connection of 
adhesion sites to the actin cytoskeleton via integrins. Vinculin is enriched in focal 
adhesions and adherens adherens junctions and has a critical function in governing cell-
matrix adhesion, promoting focal adhesion formation by regulating integrin clustering, 
force generation and cell migration (Peng X., Nelson E.S. et al. 2011) . Cells depleted 
of Vinculin have reduced adhesion to a variety of ECM proteins, fewer and smaller 
adhesions compared with wild type cells, alterations in cell migrations (Coll J.L., Ben-
Ze'ev A. et al. 1995; Volberg T., Geiger B. et al. 1995; Saunders R.M., Holt M.R. et al. 
2006) 
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Figure 3.15: Protein expression pattern of Vinculin 
Protein expression patterns of Vinculin (117 kDa) in the three breast cell lines MDA-MB-231 MCF-7 
and HBL-100. 10 mg of proteins from the whole cell protein lysates were loaded, separated by SDS 
PAGE and stained by immunoblotting with primary and secondary antibodies. Β-actin (42 kDa) was 
used as control. Numbers below pictures represent the ratio of the densiometric signal intensitiy of the 
detected protein Vs the densiometric signal intensity of actin. ND, not detected 
Vinculin showed to have a similar expression pattern of Integrin αvβ3 in the analyzed 
cell types. Vinculin  was highly expressed in MDA-MB-231 and HBL-100 in 
comparison to MCF-7. The intensity ratios detected for Vinculin in MDA-MB-231 
were similar to those detected in HBL-100 (0,7 vs 0,6,  respectively). 
 
Molecular marker MDA-MB-231 MCF-7 HL-100 
E-cadherin - ++ - 
CK 8 + ++ + 
CK 18 + ++ + 
Vimentin + - + 
Integrin αvβ3 + - + 
Vinculin + - + 
++ positive (high expression) 
+  positive (low expression) 
-  negative 
 
Table 3.2: Western Blot results. 
Summary of the molecular markers expression patterns in MDA-MB-231, MCF-7 and HBL-100 cell 
lines. Symbols “+ “and “–“ means positive and negative result, respectively. When all three cell lines are 
positive for a certain molecular markers symbols “++” and “+” discriminate samples with higher or 
lower expression respectively. 
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3.3 Super resolution imaging: comparative analysis of the cytoskeleton 
morphology of the breast cell lines 
We investigated the actin cytoskeleton structure of cell types by immunostaining with 
Phalloidin 590 (attotech). Cells were fixed, stained and imaged with STED microscopy 
as described in 2.4. Images were acquired with pixel sizes of 20 nm × 20 nm and a 
pixel dwell-time of 1 ms. In addition to the STED images, confocal images were 
recorded (Fig. 3.16). 
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Figure.3.16: Comparative actin cytoskeleton imaging by STED and Confocal microscopy 
Actin cytoskeleton of MDA-MB-231 cells (above), MCF-7 cells (centre) and HBL-100 cells (below) was 
marked by Phalloidin 590. Cells were imaged with STED microscopy (left) and Confocal microscopy 
(right). Scale bar is 5um. 
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Cytoskeleton imaging clearly revealed a miss-regulation in the organization of the actin 
filaments in cancer cells MDA-MB-231 and MCF-7 compared to HBL-100. This 
difference can be observed from both STED and Confocal imaging, details are 
particularly clear  for STED. 
HBL-100 exhibited an actin network with thin filaments homogeneously distributed 
under the cell surface. MDA-MB-231 and MCF-7 exhibited thicker filaments, a less 
homogeneous network and the presence of actin drifts. In particular, MDA-MB-231 
cells showed very thick and abundant actin filaments confined at the edge of the cells; 
spot like actin accumulations in the cell body. 
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3.4 MALDI-MS analysis of the cells lipid composition 
We analyzed the whole lipid extracts from the three cell lines MDA-MB-231, MCF-7 
and HBL-100 by means of MALDI-MS. We performed semi-quantitative analysis by 
applying the same amount of lipids on the matrix and comparing the spectra. 
Experiments were repeated twice, using in parallel 2,5-dihydroxybenzoic acid (DHB) 
and 9-aminoacridine (9-AA) as matrix. 
DHB is used predominantly for lipid studies. The application of DHB offers the 
possibility to record both positive- and negative-ion spectra from the same sample, but 
due to its acidic property (pK=2.97 in water)(Schiller J., Suss R. et al. 2007), it shows 
lower suitability in negative-ion mode. This is disadvantageous because the detection of 
the individual lipid classes in the positive-ion mode varies significantly, and it has been 
noted that the presence of lipids with quaternary ammonia groups, such as in 
phosphatidylcholines (PCs), lyso-phosphatidylcholines (LPCs) as well as 
sphingomyelins (SMs), may lead to the suppression of the signals of other lipid classes, 
such as phosphatidylethanolamines (PEs), in a lipid mixture (Petkovic M., Schiller J. et 
al. 2001) 
9-AA is more suitable than DHB for negative-ion mode measurements, under which 
lipid classes such as PEs can be analysed without the suppression effect in the presence 
of PCs in positive-ion mode. This highlight of 9-AA comes from its basicity (pK_9.99 
in water) (Schiller J., Suss R. et al. 2007). 
Therefore, to be able to detect different lipid classes and have a complete overview of 
the cells lipid composition we performed our experiments in parallel using both 
matrixes. 
MALDI-MS spectra with matrix DHB and 9-AA are reported in figures 3.16 and 3.17. 
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Figure 3.17 
Positive ion MALDI-MS spectra with DHB matrix of (a) MDA-MD-231 (b) MCF-7 and (c) HBL-100 
cells lipid extracts.  
As expected, the Positive ion MALDI-MS spectra obtained with DHB matrix were 
dominated by Phosphatidyl-choline (PC) signals. In these spectra no significant 
differences were found among the three cell types, as reported in Fig  3.17.  
 
 
Fig 3.18 
Negative ion MALDI-MS spectra with 9-AA matrix of (a) MDA-MD-231 (b) MCF-7 and (c) HBL-100 
cells lipid extracts.  
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As shown in Fig 3.18, the negative ion MALDI –MS spectra obtained with 9-AA 
matrix showed some differences at the level of some PEs and some PIs. In particular, 
spectra corresponding to MCF-7 and HBL-100 were similar when compared to MDA-
MB231. Main differences observed in MDA-MB-231 spectrum were an higher 
expression of the Phosphatidylinositols PI 18:0/20:4-Na+ and PI 18:0/20:3 Na+ and 
lower expression of the Phosphatidylethanolamines PE 18:0/18:1-H+ and PE 18:0/18:2-
H+ 
A detailed assignment of the peaks detected in our spectra is listed in Appendix  
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4. COMPARATIVE DISCUSSION ON THE DIFFERENCES 
BETWEEN THE BIOMECHANICAL PROPERTIES OF THE 
BREAST CELL LINES  
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We have built an Optical Tweezers (OT) setup in which a trapped microbead is used to 
grab the cell plasma membrane and pull a tether of several microns to measure the 
viscoelastic properties of the cell membrane. We first investigated on temperature 
dependence of the cell viscoelastic properties. The results obtained from experiments 
performed at room temperature and physiological temperature show a considerable 
variation of the viscoelastic properties. Afterwards, a more detailed analysis of the FE 
curves has been proposed using the Kelvin model. From these analyses some 
viscoleastic characteristics, such as tether stiffness, tether force, viscosity of the cell 
membranes can be extracted. 
We used this experimental technique and this data analysis approach to measure and 
compare the local viscoelastic properties of two breast cancer cell lines, MDA-MB-231 
and MCF-7, as tumour models of breast cancer related to different aggressiveness.  A 
third immortalized cell line HBL-100, derived from the milk of an apparently healthy 
woman was used as control. 
Afterwards we further investigate on the mechanical properties of the cell lines using 
other two experimental techniques that are currently used to extract mechanical 
properties of cancer cells: Atomic Force Microscopy (AFM), and Microfluidic Optical 
Stretcher (MOS). With AFM we locally indented cells with a bead attached to the 
cantilever to measure the Young’s Modulus. Both OT and AFM perform local 
measurements to test the mechanical properties of the cell membrane as well as the 
underlying region. OT tether membrane approach gives viscoelastic information about 
cytoskeleton-membrane interaction while AFM gives information on the elasticity only, 
but measurement involves a larger region of the cell under bead indentation. Finally, 
we used MOS to further characterize the cell as a whole body: cells in suspension were 
deformed by the radiation pressure of light. In conclusion, we used three different 
approaches to evaluate different mechanical properties of the analysed cells. 
Up to now, most of the studies related to the biomechanical properties of 
neoplasticcells have compared mechanical properties of tumour cells versus to normal 
ones or non-transformed cells (Lekka M., Laidler P. et al. 1999; Zhang G., Long M. et 
al. 2002; Guck J. 2005; Park S., Koch D. et al. 2005). The aim of the present study was 
to investigate if mechanical properties of cells were able to discriminate between cancer 
cells related to different aggressive behaviours. Our data strongly support the fact that 
biomechanical measures, despite the experimental approach used, are able to 
significantly discriminate between tumour and control. By the use of these three 
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different approaches we obtained different information: in the case of AFM and MOS 
the results were comparable, since both revealed that HBL-100 cells were more 
deformable than cancer breast cancer cells. On the contrary, OT revealed that cancer 
cells exhibited a less stiff plasma membrane and lower membrane bending rigidity than 
control cell type. These different behaviours could be explained with the nature of the 
measurements.: MOS and AFM compress the entire cell or only a region respectively, 
involving a larger region, if compared to OT measurements. In membrane tether 
pullings a much restricted cell region and its underlying region are involved, thus the 
measures are more local taking in consideration also the viscous component of the 
plasma membrane. 
If these measurements were able to discriminate tumour and control, they could not 
discriminate different types of tumours of the same origin, but with different 
aggressiveness. We observed very high standard deviations suggesting that cell lines 
were heterogeneous in terms of biomechanical properties and a net discrimination in 
terms of elasticity was difficult. However, a trend could be observed: in all three cases 
if we consider the two breast cancer cells taken together, MCF-7 showed to be weakly 
more resistant to deformation compared to MDA-MB-231 that are more aggressive. 
 
In particular, our results from OT experiments showed that lower tether stiffness and 
membrane bending rigidity values were associated to breast cancer cells MDA-MB-231 
and MCF-7, while higher values were significantly associated to HBL-100 cell line. As 
already mentioned there was no significant discrimination between the two breast 
cancer cell lines, but an increase of tether stiffness in MCF-7 compared to MDA-MB-
231 could be observed as a trend. Viscosity, compared to elastic parameters, exhibited 
an inverse tendency: highest viscosity values were observed in the more aggressive cell 
line MDA-MB-231, values gradually decreased with an evident trend in MCF-7 and in 
HBL-100,  but with no significant differences. 
We interpret the Force- Tether Elongation curves derived from our OT experimental 
data with the assumption that the force necessary to pull a tether from membrane must 
overcome the membrane bending rigidity, the membrane tension, and also the adhesion 
of the phospholipid membrane bilayer to the cytoskeleton and the viscous resistance of 
the phospholipid bilayer (Sheetz and Dai 1996; Raucher and Sheetz 1999; Sheetz, 
2001). Thus, plasma membrane structure and composition, is supposed to give a strong 
contribute to viscoelastic properties of cells. Thus far, the lipid metabolism of cancer 
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has been predominantly investigated at the level of genes and many of these have been 
shown to affect tumorigenesis. Nevertheless, the precise molecular composition of 
lipids in tumours remains generally poorly characterized (Hilvo M., Denkert C. et al. 
2011). 
It is known that activation of lipid metabolism is an early event in carcinogenesis and a 
central hallmark of many cancers, including breast cancer (Chajes V., Lanson M. et al. 
1995). Thus, we investigated on possible alterations in the lipid membrane composition 
of cells, that could eventually be correlated to these alterations in the viscoelastic 
properties of cells. To fulfil this proposal we used matrix-assisted laser desorption and 
ionization (MALDI) mass spectrometry (MS) to characterize the lipid composition of 
cells with semi-quantitative analysis, and compare the results for the different cell 
types. Despite MALDI-MS is a well established technique in the study of proteins, it is 
also very useful in lipid research, because it is fast, sensitive, and provides very simple 
mass spectra without major fragmentation of the analyte (Fuchs B., Süß R et al. 2010). 
From our results, we could not observe any significant difference at level of PCs 
(Phosphatidylcolines). However, MDA-MB-231 exhibited a significant downregulation 
of PEs (Phosphatidyletanholamines) and upregulation of PIs (Phosphatidyliinositoles) , 
compared to the loess aggressive MCF-7 and the control cell line HBL-100.  Our 
results are supported by a previous paper (Hilvo M., Denkert C. et al. 2011) in which a 
study based on breast cancer tissues reported a striking difference in the lipid profiles 
between the breast tumour and normal tissue samples. Membrane phospholipids 
including PEs, and PIs, were altered in tumors. Interestingly, the altered phospholipid 
metabolism of the tumour samples was related to ER status and tumour grade. These 
results suggest that the alterations in lipid metabolism could be directly involved in the 
alterations of the viscoelastic properties of membrane cancer cells. However, this 
observations needs to be confirm with further experiments. 
 
Taking in consideration the two other biomechanical tools used to probe cell 
mechanical properties, AFM and MOS, we could observe a certain coherence in the 
results. Young’s Modulus values, that are measuring the resistance to deformability of 
the three cell types obtained by AFM were quite spread thus a net discrimination in 
terms of elasticity was difficult. However we could observe a trend: the less aggressive 
cancer cells MCF-7 showed higher median values of Young’s Modulus, and thus a 
major resistance to deformability, than the highly aggressive MDA-MB-231 cells. The 
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same has been seen in MOS results: MCF-7 showed higher deformation rates compared 
to MDA-MB-231.  
Both AFM and MOS observed differences were not significant, however these results 
suggest a trend , which is supported by previous studies here reported. Distinct cell 
lines from both human and murine tumours have been assessed in terms of their elastic 
responses to force stimulation by AFM; namely, human bladder (Lekka M., Laidler P. 
et al. 1999) , prostate (Faria E.C., Ma N. et al. 2008), breast (Cross 2007), mesothelial 
(Cross S.E., Jin Y.S. et al. 2008), cartilage (Darling E.M., Zauscher S. et al. 2007) and 
blood (Rosenbluth M.J., Lam W.A. et al. 2006) as well as murine ovarian (Carl P. and 
Schillers H. 2008) and fibroblast cells (Nikkhah M., Strobl J. et al. 2010). All groups 
have suggested that cancerous cells are “softer” or deform at a higher rate than their 
“normal” or non transformed counterparts by means of their respective elastic moduli. 
Previous measurements with MOS have shown that optical deformability was sensitive 
to monitor the changes during the progression of mouse fibroblasts and human breast 
epithelial cells from normal to cancerous and even metastatic state, showing 
transformed cells more deformable than their normal counterparts. (Guck J. 2005). 
Our data agree with those studies since we were able to significantly group tumour cells 
versus control, but our MOS results showed that the control cell lines HBL-100 had 
significantly higher deformability rates compared to cancer cells. The same was 
observed with AFM, but in this case the difference was not significant. 
The biomechanical measures we performed in this study strongly suggested that HBL-
100 are a cell type with a deformation pattern dissimilar from “normal” cell. This 
observation was confirmed by the analysis of different molecular biomarkers.  
We verified by immunoblotting the expression patterns of some molecular markers 
associated to malignancy progression and  to epithelial to mesenchymal transition 
(CK8/18, Vimentin, E-cadherin); and two proteins involved in cell-adhesion and cell 
migration (Integrin αvβ3 and Vinculin). As expected we confirmed the low aggressive 
status of MCF-7 compared to MDA-MB-231. However HBL-100 marker expression 
pattern was identical to MDA-MB-231, thus more similar to an aggressive cancer cell 
line rather than a non cancerous control.  
HBL-100 were positive for Vimentin, which expression in epithelial cells is a hallmark 
of EMT. Data on vimentin reactive cells in benign and malignant breast tissue have 
been described by many authors suggesting its usefulness in identifying cases with 
clinically aggressive behaviour of tumours and poorer prognosis (Zajchowski D.A., 
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Bartholdi M.F. et al. 2001; Korsching E., Packeisen J. et al. 2005), (Raymond W.A. and 
Leong AS-Y. 1989), (Raymond W.A. and Leong AS-Y. 1989). It may be explained by 
correlation of vimentin expression and estrogen receptor negativity (Sommers C.L., 
Walker-Jones D. et al. 1989; Domagala W., Lasota J. et al. 1990), high Ki-67 level 
(Domagala W., Lasota J. et al. 1990) and poor differentiation of tumours (high grade) 
(Domagala W., Wozniak L. et al. Am J Pathol 1990). Only few reports are in opposite, 
as they showed that vimentin expression did not predict patient survival (Heatley M.K., 
Ewings P. et al. 2002).  
Also from the results of the cytokeratins 8/18 immunoblotting, MDA-MB-231 and 
HBL-100 showed to have similar patterns. Cytokeratins 8/18 are considered markers of 
malignancy: they are usually used as molecular markers to distinguish Luminal 
carcinomas from Basal –like carcinomas, that are usually more aggressive  (Delgallo 
W.D., Rodriguez J.R.P. et al. 2009). As expected MCF-7 strongly expressed both 
cytokeratins CK8 ⁄ 18 and MDA-MB-231 exhibited weak positivity; similar to MDA-
MB-231 HBL-100 exhibited weak positivity. 
Regarding E-Cadherine, both HBL-100 and MDA-MB-231 resulted negative. This is a 
protein which exerts an evident invasion-suppressing role in tumour cell lines and in 
vivo tumour model systems (Vleminckx K., Vakaet Jr L. et al. 1991; Frixen U.H., 
Behrens J. et al. 1991.): forced expression of E-cadherin decreased proliferation of 
different mammary carcinoma cell lines (Meiners S., Brinkmann V. et al. 1998; St 
Croix B., Sheehan C. et al. 1998.). E-cadherin is expressed in normal adults in luminal 
epithelial cells. Temporary down-regulation of E-cadherin was found in budding 
lobules invading the stroma of breast tissue (Daniels C., Strickland P. et al. 1995). In 
breast cancer partial or total loss of E-cadherin expression correlates with loss of 
differentiation characteristics, acquisition of invasiveness potentiality, increased tumor 
grade, metastatic phenotype and poor prognoses (Heimann R., Lan F.S. et al. 2000) 
(Siitonen S.M., Kononen J.T. et al. 1996). 
Finally, HBL-100 (and MDA-MB-231) showed positivity for Integrin αvβ3 and 
Vinculin. The integrins are trans-membrane receptors linked to the actin cytoskeleton, 
involving vinculin as on of its intermediaries. Thus, both these proteins are involved in 
cell-cell and cell-extracellular matrix (ECM) interactions, cell mobility and migration. 
Detailed studies of integrin expression in benign breast lesions (fibroadenoma or 
papilloma) and mammary carcinomas show patterns of integrin type and distribution 
that are altered in comparison with normal breast tissue (Mizejewski G.J. 1999) In 
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particular in breast carcinomas αvβ3 mediates bone metastasis through the enhanced cell 
adhesion (Felding-Habermann B. and al. 2001; McCabe N.P., De S. et al. 2007). In 
their study, Desgrosellier et al. (Desgrosellier J.S., Barnes L.A. et al. 2009) compared 
αvβ3 expression in multiple matched pairs of primary tumors and lymph node 
metastases from breast cancer patients: interestingly several cases were observed in 
which αvβ3 expression was enriched in the lymph node metastases in comparison with 
the primary tumor. In ”in vitro” studies, high αvβ3 expression in breast tumors was 
positively correlated with the cell's ability to endothelial adhesion and migration, thus 
increasing the metastatic potential (Mizejewski G.J. 1999). Furthermore, αvβ3 integrin 
co-localizes with the ECM metalloproteinase-MMP2 on the surface of invasive 
melanoma cells thereby facilitating tumor cell invasion by degradation of the ECM 
(Koukoulis G.K., Howeedy A.A: et al. 1993). Taken together these information suggest 
αvβ3 integrin in breast cancer as a marker of the metastatic phenotype. 
 
The fact that HBL-100 presented markers of aggressiveness is in agreement with 
previous papers. It has been seen in 2006 by Sheridan and colleagues that both MDA-
MB-231 and HBL-100 possessed a large (>30%) CD44+/CD24- subpopulation. CD44 
and CD24 have been shown to regulate invasion and metastasis of breast cancer cells 
either positively or negatively. Although most studies have shown CD44-mediated 
invasion of breast cancer cells (Bourguignon L.Y. 2001; Hill A., McFarlane S. et al. 
2006), Lopez and coworkers (Lopez J.I., Camenisch T.D. et al. 2005) showed 
inhibition of breast cancer metastasis by this molecule. Similarly, CD24 has been 
shown to promote (Baumann P., Cremers N. et al. 2005) or inhibit (Schabath H., Runz 
S. et al. 2006) invasion and metastasis of breast cancer cells. Sheridan and colleagues 
found out that breast cancer cells with CD44+/CD24- subpopulation express higher 
levels of pro-invasive genes and have highly invasive properties, even if this phenotype 
seems to be not sufficient to predict capacity for pulmonary metastasis (Sheridan C., 
Kishimoto H. et al. 2006)  A possible explanation for this discrepancy could be the 
problem related to cell culturing process.  Cell lines, infact, are widely used since they 
are easy to handle and represent an unlimited self-replicating source that can be grown 
in almost infinite quantities. However, cell lines undergo to genotypic and phenotypic 
drift while becoming immortalized, and from their continual culture and subpopulations 
may arise and cause phenotypic changes over time by the selection of specific clones 
(Burdall Sarah E. 2003) changing the characteristic of the cell line. 
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HBL-100 was developed from milk of an apparently healthy 27-year-old Caucasian 
woman obtained on day 3 after delivery (Polanowski F.D. et al. 1976; Gaffney E.V, 
1982; Caron de Fromentel C. et al. 1985. The milk donor was followed for several 
years with clinical and mammographic evaluations at regular intervals with no 
detectable breast lesion (Gaffney E.V. 1982). From literature data emerged that at low 
number of passages (below P 35), when the cells were inoculated by different routes 
into adult nude mice, no tumors were obtained. By contrast, carcinomas consistently 
appeared when the cells were tested at passage 103 or later (Ziche M. et al. 1982) 
Furthermore, it was shown that during the course of their progression toward neoplastic 
transformation, the HBL-100 cells displayed an increasing capacity to induce 
angiogenesis and a loss of fibrin clot retraction activity, properties both associated with 
the malignant phenotype (Ziche M. et al. 1982). For these reason we used HBL-100 
between passage 9 to 25, in which HBL-100 cells are supposed to represent an early 
stage of the neoplastic progression. Nevertheless, biomechanical and proteomic 
characterization describes HBL-100 as a cancer cell type at a late and not early stage of 
the neoplastic progression. 
A second explanation that could explain the HBL-100 aggressive behaviour is related 
to its nature. HBL-100 are derived from the milk of a donor demonstrate that they are 
not referred to the breast in a general situation, but particular, which is related to the 
production of milk. There is emerging evidence that the mammary epithelium is 
arranged as a hierarchy that spans from stem cells to differentiated hormone-sensing, 
milk-producing and myoepithelial cells. It is well established that estrogen is an 
important mediator of mammary gland morphogenesis and exposure to this hormone is 
associated with increased breast cancer risk (Stinql J. 2011). Mammary gland 
development occurs in three distinct stages during the lifetime of the female mammal: 
in embryonic, pubertal and reproductive life. At each of these developmental stages, 
different signalling molecules induce changes in both the epithelium and the 
surrounding stroma. However, it is during pregnancy that the most dramatic changes 
occur, resulting in a massive increase in the number of epithelial cells and in their 
function. Pregnancy initiates the development of a new epithelial lineage, the alveolar 
cells, which form the milk-producing lobuloalveolar structures. These cells become 
redundant at the end of lactation and are removed in an exquisitely controlled process 
of tissue remodelling coupled with extensive cell death. All of these events require not 
only steroid hormones but also sequential signalling by cytokines (Watson C.J. et al. 
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2011) The HBL-100 cell lines are so far representative of the lactation period and this 
fact could represent a possible explanation for the molecular pattern detected in these 
cells. 
To further investigate on cell types and their nature, and to find out a possible 
correlation between their malignancy status and their mechanical properties, we used 
the cytoskeleton structure and organization as a parameter to discriminate the cell 
types. 
The driving force that contrasts membrane protrusion is localized in the polymerization 
of submembrane actin filaments. Cytoskeleton imaging by STED microscopy could 
group the two breast cancer cells MDA-MB-231 and MCF-7 showing a deregulation in 
the organization of the actin filaments compared to HBL-100. The control cell line 
showed an actin network with thin filaments homogeneously distributed under the cell 
surface. On the other hand MDA-MB-231 and MCF-7 exhibited thicker filaments, a 
less homogeneous network and the presence of actin drifts.. This deregulation was 
expected, since malignant cancer cells utilize their intrinsic migratory ability to invade 
adjacent tissues and to metastasize (Yamaguchi H. and Condeelis J. 2007). This 
difference among the breast cancer cell lines and the control ,suggested the non 
neoplastic nature of HBL-100 supporting the hypothesis that its anomalous 
biomechanical characteristics and molecular pattern are due to its nature of epithelial 
cells related to an exceptional situation as lactation, and not to a real malignant nature. 
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5. FINAL REMARKS AND CONCLUSIONS 
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One of the most debated issue in oncology nowadays is the biomechanical 
characterization of tumour cells and its relationship with the progression of the disease. 
Tumour invasion and metastatization are strictly correlated with alterations in cell 
adhesion, migration properties and thus in cell mechanics. To give some contribution to 
this topic we studied three cell lines with different characteristics, representing different 
stages of the progression through malignancy: two breast cancer cell lines, one more 
aggressive than the other, and one cell line supposed to be from normal breast lactating 
cell. 
The cell lines were submitted to physical stimulation by membrane tether pulling 
experiments with Optical Tweezers (OT), indentation experiments by Atomic Force 
Microscopy (AFM) and optical deformability tests by Microfluidic Optical Stretcher 
(MOS). To better explain the physical results we characterized the cell lines by protein 
biomarkers expression pattern analysis and investigated on the actin cytoskeleton 
organization and structure. Furthermore, phospholipid composition of cell membrane 
was studied by MALDI-MS analysis.  
 
We can conclude that our results are suggesting: 
 
1. The different biomechanical experimental approaches used in this work characterize 
different aspects of cell mechanical properties and thus could help for a extensive 
analysis of the cell mechanics. Membrane tether formation by OT is a local measure 
which gives visco-elastic information about cytoskeleton-membrane interaction; 
indentation experiments by AFM gives information on the elasticity only, but 
involves a larger region of the cell; MOS test the whole cell deformation by the 
radiation pression of light. With three experimental approaches we were able to 
evaluate different mechanical properties related to cell membrane or to the entire 
cell. 
 
2. These experiments could discriminate between normal and tumour cells, but were 
unable to discriminate tumour cells with difference in aggressiveness. 
 
3. We were able anyway to show a trend among the tumour cell types: membrane tether 
pulling experiments with OT showed that the less aggressive cell line have stiffer 
membranes and thus to be more resistant to membrane deformation compared with 
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the more aggressive ones; indentation experiments with AFM and optical 
deformability tests with MOS showed that the less aggressive cells have higher 
resistance to deformation compared to the more aggressive ones. 
 
4.We could better explain the differences between cells comparing mechanical analysis 
with expression patterns of some molecular markers associated to epithelial 
differentiation (CK8/18), markers associated to epithelial to mesenchymal transition 
(E-cadherin and vimentin), markers involved in cell migration and adhesion 
(integrin άvβ3 and vinculin). We confirmed the neoplastic nature of the breast 
cancer cell lines considered, and their aggressive status. However, the mechanical 
and protein expression analysis of the control cell line suggested a pattern dissimilar 
from a “normal” non tumorigenic cell line. 
 
5. We explained the anomalous behaviour of the control cells with its nature: the cell 
line was derived from the milk of an apparently healthy milk donor. We suppose its 
anomalous characteristics are due to fact that it is representative of an exceptional 
situation such as lactation, mimicking  malignant nature. 
 
6. Actin cytoskeleton images by STED (Stimulated Emission and Depletion) and 
confocal microscopy confirmed the non malignant nature of the control cell line. We 
could associate an homogeneous and ordered actin filament organization to the 
control cell line and observed a more dysregulated actin filaments organization in 
the tumour cell lines 
 
7. Phospholipids analysis gave us some major results that could explain differences in 
membrane stiffness: downregulation of some PEs (Phosphatidylethanolammines) 
and upregulation of some PIs (Phosphatidylinositoles) were found in the more 
aggressive cell lines associated to softer membrane. 
 
Our results are completely preliminary and need further confirmation in breast and 
other tumour cell lines. 
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APPENDIX 
Assignment of the m/z values detected 
within this work 
Peak Position Assignement 
714,5 PE 16:0/18:2-H+ 
716,5  PE 16:0/18:1-H+ 
732,6  PC 16:0/16:1+H+ 
742,5  PE 18:0/18:2-H+ 
744,5  PE 18:0/18:1-H+ 
760,6  PC 16:0/18:1+H+ 
766,5  PE 18:0/20:4-H+ 
782,6  PC 16:0/20:4+H+ 
788,6  PC 18:0/18:1+H+ 
788,5  PE 18:1/22:6-H+ 
788,5  PS 18:0/18:1 Na+ 
808,7  PC18:0/20:4+H+ 
810,9  PC 18:0/20:4+H+ 
835,5  PI 16:0/18:1-Na+ 
861,5  PI 18:0/18:2-Na+ 
863,5  PI 18:0/18:1-Na+ 
885,5  PI 18:0/20:4-Na+ 
887,5  PI 18:0/20:3 Na+ 
911,5 PI 18:0/22:5-Na+ 
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